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Glucocorticoids (GCs) are administered to neonates and to pregnant mothers for the treatment of 
complications arising from premature birth and for congenital adrenal hyperplasia; however, 
antenatal exposure to GCs may trigger adverse neurological side effects due in part to reduced 
neural progenitor cell (NPC) proliferation. While many established cell cycle regulators impact 
NPC proliferation, other molecules also influence proliferation. An example is the gap junction 
protein connexin 43 (Cx43), although its precise role and mechanism of regulation remain 
unresolved. Gap junction intercellular communication (GJIC) is influenced by GCs in some 
cells, but such hormone effects and resulting functional consequences have not been examined in 
coupled stem cells. We found that both continuous and transient exposure of embryonic (E14.5) 
mouse neurosphere cultures to the glucocorticoid dexamethasone (DEX) limits proliferation of 
coupled NPCs, which is manifested by both a reduction in S phase progression and enhanced cell 
cycle exit. A short (i.e. 1hr) DEX treatment also reduced GJIC as measured by live cell 
fluorescence recovery after photobleaching (FRAP). GC effects on GJIC in NPCs are 
transcription-independent and mediated through plasma membrane glucocorticoid receptors 
(GRs). This non-classical pathway appears to operate through lipid-raft associated GRs through a 
site-specific, MAPK-dependent phosphorylation of Cx43, which is linked to GR via caveolin-1 
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and c-src.  These effects were absent in caveolin-1 knockout NPCs indicating that caveolin-1 is 
an essential component for this signaling pathway.  As transient pharmacologic inhibition of 
GJIC triggers reduced S phase progression but not enhanced cell cycle exit, the non-classical GR 
signaling pathway may operate via distinct downstream effectors to alter the proliferative 
capacity of NPCs.  
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1.0  INTRODUCTION 
Glucocorticoid hormones (GCs) mediate a wide array of physiological actions following their 
binding to the glucocorticoid receptor (GR).  The principal effects of GCs are mediated by 
transcriptional responses (i.e. activation or repression) that follow either the direct binding of a 
GR-ligand complex to glucocorticoid response elements (GREs) contained within target genes, 
or the indirect association of the receptor with other DNA elements or DNA-bound transcription 
factors (Haller et al. 2008).  However, GR may also act via nongenomic (or non-classical) 
mechanisms to mediate rapid cellular responses to GCs in the absence of measurable alterations 
in gene expression (Qiu et al. 2001; Haller et al. 2008; Pasricha et al. 2010).  Given the wide use 
of GCs in a number of clinical settings, such as for the treatment of complications arising from 
premature birth (Yeh et al. 2004), and the evidence suggesting adverse developmental 
consequences from GC exposure (Yeh et al. 2004), gaining a full understanding of mechanisms 
of GC action is of particular importance.   
 In order to lay the foundations for the particular studies of GC action that I conducted for 
this thesis, this introduction has been divided into four major sections.  Each section focuses on 
the primary elements of my thesis work.  In the first major section, I explore steroid hormones 
and their receptors with particular attention to GCs and GR.  This was the principal focus of my 
studies.  The second section explores gap junctions and the connexin proteins that constitute gap 
junctions.  A major goal of this work was to link GR activation to the modulation of gap junction 
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intercellular communication (GJIC).  In the final two sections of the introduction I summarize 
some of the relevant literature on caveolin-1 and ERK-1/2, which I hypothesized to be the major 
signaling proteins linking the activation of GR to changes in GJIC. 
1.1 GLUCOCORTICOID HORMONES: THE HYPOTHALAMIC-PITUITARY-
ADRENAL AXIS 
The physiological release of GC hormones is under the control of the hypothalamic-pituitary-
adrenal (HPA) axis.  Under conditions of stress, neurons in the paraventricular nucleus (PVN) of 
the hypothalamus are activated and release corticotropin releasing hormone (CRH) and arginine 
vasopressin (AVP).  CRH and AVP act synergistically to stimulate the release of 
adrenocorticotropic hormone (ACTH) from the anterior pituitary, which, in turn, acts on the 
adrenal glands to release GC hormone (Figure 1).  In humans the naturally occurring GC is 
cortisol, while in rodents, it is corticosterone (Groeneweg et al. 2011). 
 
Figure 1. HPA Axis:  
CRH and AVP release from the paraventricular nucleus of the hypothalamus stimulates ACTH 
production in the anterior pituitary gland.  ACTH acts on the adrenal gland to stimulate 
production of cortisol.  Cortisol inhibits hypothalamic production of CRH and AVP as well as 
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ACTH production by the anterior pituitary, thus maintaining homeostasis through a negative 
feedback loop (Groeneweg et al. 2011). 
 
In addition to the release of GC during periods of physiological and/or psychological 
stress, there is also a natural circadian rhythm of GC release with hormone levels peaking prior 
to waking (e.g. 8AM for humans) as well as an underlying ultradian pattern of GC release with a 
period of approximately 1hr (Young et al. 2004).  Disruptions in circadian rhythms have been 
associated with mood disorders as well as other pathological conditions such as autoimmune 
diseases (Cutolo et al. 2006; Mendlewicz 2009).  Alterations in the circadian rhythms of cortisol 
secretion have been specifically linked to bipolar disorder as well as rheumatoid arthritis, 
indicating that the timing of hormone release plays important roles in normal physiology 
(Cervantes et al. 2001; Cutolo et al. 2006). 
GCs bind to both GR and the mineralocorticoid receptor (MR).  The MR has a higher 
affinity for GC than GR.  Measurements of GR from CNS tissues revealed a Kd (disassociation 
constant) for cortisol that was between 2.5-5.0nm while the Kd for MR was approximately 10 
fold lower (Reul and de Kloet 1985).  Consequently, MR tends to be occupied even when 
circulating GC levels are at their nadir under physiological conditions (Groeneweg et al. 2011). 
Furthermore, GR is expressed throughout the brain, whereas MR expression is highest in the 
hippocampus, is moderately expressed in the amygdala and the prefrontal cortex, and is 
expressed only at very low levels in other brain regions (Groeneweg et al. 2011).   
Another important factor in the selective activation of GR or MR is the expression of the 
11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) enzyme.  The type 2 enzyme inactivates 
cortisol by converting it to a ketone product (cortisone) (Holmes et al. 2003).  The most well 
characterized role of 11β-HSD2 is in the kidney where it is highly expressed.  By inactivating 
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renal cortisol, this enzyme preserves the ability of MR to be activated only by its primary in-vivo 
ligand, aldosterone. Mutations in the gene for 11β-HSD2 that reduce its activity lead to over-
activation of renal MR by cortisol and increased absorption of sodium and water in the nephron, 
loss of potassium, and hypertension (Holmes et al. 2003).  The precise roles of 11β-HSD2 in the 
developing and adult brain are less well characterized, but the enzyme is known to be expressed 
in the fetal and, to a much more limited extent, adult, brain, and may impact GC activity.  11β-
HSD2 is also highly expressed in the placenta where it acts as a barrier preventing maternal 
cortisol from having effects on the developing fetus.  This enzyme is expressed in the fetal brain 
starting at around mid-gestation.  Expression is turned off post-natally in most brain areas except 
for the thalamus and cerebellum (Holmes et al. 2003).  Importantly, the synthetic GC 
dexamethasone (DEX), which is commonly used in clinical settings, is a poor substrate for 11β-
HSD2 and is therefore capable of crossing the placenta and acting on fetal tissue (Holmes et al. 
2003). 
Activated GR is capable of producing physiological effects by impacting transcription 
and by affecting cellular processes independently of transcriptional effects.  The following two 
subsections will focus on these two major mechanisms of GR action.   
1.2 GR: CLASSICAL SIGNALING 
GR is a ligand-dependent transcription factor belonging to the nuclear hormone superfamily of 
DNA binding proteins (Cato et al. 2002).  As with other members of this superfamily, the amino 
acid sequence of GR can be divided into 6 major regions.  These include a variable N-terminal 
A/B region, a conserved DNA binding domain (DBD) C region, a linker D region, a conserved 
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ligand-binding domain (LBD) E region, and a variable F region that lacks a known function 
(Aranda and Pascual 2001) (Figure 2).  
 
 
Figure 2: Schematic of a Nuclear Hormone Receptor 
Most nuclear hormone receptors, including GR, have 6 domains.  The variable A/B domain 
contains a ligand independent transactivation domain.  The conserved C region recognizes 
specific DNA sequences and is linked to the E domain by a linker D region.  The E and F regions 
contain the ligand binding domain (LBD).  In addition, the ligand dependent transactivation 
domain is proximal to the LBD near the c-terminus of the receptor (Aranda and Pascual 2001).  
Ligand dimerization of most nuclear hormone receptors occurs through portions of the LBD and 
the DBD.  Ligand-dependent dimerization of GR has been shown to be highly reliant on the 
LBD and occurs through a distinct dimerization interface in the GR LBD (Bledsoe et al. 2002).   
 
The gene encoding GR contains 9 exons, of which exons 1 and 9 are subject to alternative 
splicing (Lu and Cidlowski 2006).  The two most extensively studied and common isoforms of 
GR are GRα, which is a ubiquitous, ligand-binding isoform (henceforth referred to simply as 
“GR”), and GRβ, which does not bind ligand and acts as a negative regulator of GRα activity 
(Funder 1997; Lu and Cidlowski 2006).  GRβ has been shown to act in a dominant negative 
fashion by competing for co-activators and/or by forming a heterodimer with GRα, thus 
preventing formation of GRα homodimers that are typically necessary for GRα gene 
transactivation (Lu and Cidlowski 2006).  GR has a high affinity for the synthetic GC 
dexamethasone (DEX), lower affinity for the naturally produced hormones cortisol and 
corticosterone and limited affinity for a number of other physiological steroids including 
aldosterone and deoxycorticosterone (Funder 1997). 
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According to the “classical,” or “genomic,” view of nuclear hormone and receptor action, 
unliganded GR associates with a number of chaperone proteins.  These include the heat shock 
proteins Hsp90 and Hsp70 and the immunophilin FKBP56 (Funder 1997).  The chaperone 
proteins restrict GR to the cytoplasmic compartment (Funder 1997).  Hormone binding leads to a 
disassociation of chaperone proteins, homo-dimerization, and nuclear translocation of the GR-
ligand complex (Cato et al. 2002).  GR homodimers can then bind to glucocorticoid response 
elements (GREs) linked to GC responsive promoters in various orientations and positions 
(Figure 3).   
 
 
Figure 3: Classical GR Activation 
Hormone (GC) leads to disassociation of chaperone proteins from GR, dimerization and 
translocation of GR to the nucleus.  This is a dynamic process, and in the presence of GC, 
nuclear import of ligand-bound receptor is greater than nuclear export of the receptor.  Inside the 
nucleus, GR dimmers bind to GREs on target DNA leading to transcription of target genes. 
 
The GRE shares a high degree of sequence similarity with the DNA binding sites of other 
steroid receptors.  It consists of two inverted palindromic sequences separated by three 
nucleotides (Tsai and O'Malley 1994).  The prototypical sequence is AGAACA, although there 
can be a high degree of natural variation from this idealized consensus sequence (Aranda and 
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Pascual 2001).  In fact, progesterone, mineralocorticoid, and androgen receptors (PR, MR, AR) 
are all capable of binding to the GRE (Tsai and O'Malley 1994). Thus, the specificity of 
biological responses to the various steroid hormones relies on additional molecular components 
that are superimposed upon the core recognition by the steroid receptors to their select response 
elements. For example, the nature of select transcription factors bound in the vicinity of steroid 
hormone receptors can impact in-vivo occupancy of the receptors as well as specific chromatin 
structural features that influence the specificity of receptor binding in cells.  
In addition to activating transcription, the direct binding of GR to distinct sequences 
termed negative GREs can trigger repression of transcription (Lu and Cidlowski 2006). 
Alternatively, GR protein can directly interact with other transcription factors such as activating 
protein 1 (AP-1) and nuclear factor kB (NF-kB) and repress their transcriptional activity (Cato et 
al. 2002).  Although not as well studied, the “tethering” of GR to other DNA-bound transcription 
factors can also be associated with transcriptional activation.  
 GR also associates with various non-DNA binding co-regulator proteins that participate 
in transcriptional regulation.  The p160 family of co-activators act as adaptor proteins for binding 
of additional co-activator proteins (Lu and Cidlowski 2006).  Co-activator proteins can also help 
bind the nuclear receptor to DNA and in many instances also posses a number of enzymatic 
abilities that aid in regulating transcription.  For example, the steroid receptor co-activator (SRC) 
family has histone acetyltransferase activity that acetylates histones and other proteins at GR 
promoter sites.  CARM1 and PRMT1 are examples of co-activator proteins that are histone 
methyltransferases (Lonard and O'Malley 2005). Other co-activators are thought to provide some 
scaffolding function to regulate the assembly of multi-subunit co-regulator complexes. However, 
recent studies have also found that co-activator proteins have a number of functions apart from 
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regulating the efficiency of transcription initiation.  These functions include mRNA transport and 
translation, post-translational modifications of the translated proteins, and even cessation of 
translation by activation of the ubiquitin proteasome pathway (Lonard and O'Malley 2005; 
Lonard and O'Malley 2006).      
1.2.1 GR: Non-Classical Signaling 
Steroid hormones have also been shown to have transcription-independent mechanisms of action 
(Cato et al. 2002; Moriarty et al. 2006).  The first report of rapid actions of GCs was by Hans 
Selye who postulated that GCs may regulate “rapid adaptations to stress” (Selye 1950).  In the 
1960’s, evidence of rapid increases in cAMP following a 15 second pulse of 17-β-estradiol (E2) 
as well as evidence of E2 binding sites on the surface of endometrial cells provided some of the 
first evidence of rapid signaling by steroid hormones (Hammes and Levin 2007).  This rapid 
action of steroid hormones is often referred to as “non-genomic” signaling since it is in contrast 
to direct hormone-receptor activation or repression of transcription (i.e. “genomic” action).   
However, rapid signaling of this form may eventually lead to genomic effects, for example by 
activation of signaling cascades that impact transcription and translation.  Therefore, the terms 
“membrane initiated steroid signaling” (MISS) or “non-classical” signaling have more recently 
been used as more accurate descriptors of this form of hormone action, and I will use the term 
“non-classical” henceforth (Hammes and Levin 2007).  
Non-classical steroid actions are characterized by rapid signaling (typically within a few 
seconds to 60 minutes), insensitivity to transcriptional and/or translational inhibitors, and 
continued hormone action despite the use of cell impermeable hormone conjugates (Cato et al. 
2002).  Non-classical hormone effects may be mediated by the cognate DNA-binding steroid 
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receptor or through novel hormone-binding receptors that are not members of the nuclear 
receptor superfamily and possess no inherent DNA-binding activity. In most cases, non-classical 
effects are characterized by rapid activation of select signal transduction pathways, most 
commonly mitogen activated protein kinases (MAPKs), adenylyl cyclase (AC), and 
phosphatidylinositol 3-kinase (PI3K) (Cato et al. 2002).   
The most extensively characterized non-classical mechanisms involve estrogen and 
interaction of this steroid hormone with the major estrogen receptors (ERα and ERβ).  Our 
understanding of ER signaling can serve as a useful model for signaling by other steroid 
hormones (Cato et al. 2002).  Although an area of ongoing debate, most data suggest that non-
classical ER signaling is mediated by the classical (i.e., nuclear) ERα and ERβ receptors 
localized within the plasma membrane (Pedram et al. 2006; Hammes and Levin 2007).  In 
particular, rapid ER signaling is absent in ERα/ERβ knockout mice, and siRNA directed against 
ERα/ERβ also abrogates rapid ER signaling (Hammes and Levin 2007).  Techniques including 
immunoprecipitation and sucrose gradient fractionation have been used to establish the presence 
of ER within the plasma membrane and in association with caveolae-containing lipid rafts 
(Hammes and Levin 2007). It appears that caveolae rafts (discussed further below) provide a 
physical space where a number of signaling proteins including the steroid receptor, MAPKs, G-
proteins, and other molecules can interact (Hammes and Levin 2007).  
The membrane localization of ER has been shown to be dependent on palmitoylation of 
cysteine 447.  Mutation of this site prevents plasma membrane localization (Acconcia et al. 
2005).  Interestingly, this palmitoylation site and the surrounding nine-amino acid domain, which 
has also been found to be important in promoting palmitoylation, is present (with minor 
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differences) in GR as well, suggesting that GR membrane localization may be dependent on a 
similar post-translational lipidation (Groeneweg et al. 2011) (Figure 4). 
 
Figure 4: Palmitoylation Sequences in E-Domain of Nuclear Receptors 
The consensus palmitoylation domain for ER, AR, PR, and GR are remarkably similar sequences 
with a cysteine “C” at the three position surrounded by 9-11 amino acids.  Key: Ω=aromatic; 
φ=hydrophobic; ζ=hydrophilic.  Number represents amino acid number from the beginning of 
the E-domain (Pedram et al. 2007). 
 
Similar principles of non-classical action have also been demonstrated in GC/GR 
signaling, although the precise molecular mechanisms remain less well defined (Qiu et al. 2001; 
Cato et al. 2002).  In addition, while a significant body of the ER literature has focused on the 
role of non-classical ER signaling on cell proliferation and survival, much of the non-classical 
GR work has focused on rapid effects of GR in modulating the stress response emanating from 
the central nervous system (CNS) (Groeneweg et al. 2011).  There is an ultradian pattern of GC 
release by the adrenal glands following activation of the HPA axis (Groeneweg et al. 2011).  The 
period of this pattern of troughs and peaks is approximately 1hr and lends itself to rapid effects 
of GR on target tissue as the circulating levels of GCs drop below the concentration needed to 
maintain GR activity during troughs (Stavreva et al. 2009; Groeneweg et al. 2011).   
Although the focus of GR effects in these studies differs from the focus of this thesis, 
there appear to be general patterns and principles of rapid, non-classical GR effects that can be 
instructive.  One general principle from these studies is that rapid non-classical GC effects often 
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seem to be a precursor for more slow acting, but longer lasting, genomic GC effects.  In the 
basolateral amygdala, corticosterone increased the frequency of miniature excitatory 
postsynaptic currents (mEPSCs) within 15min (Karst et al. 2010).  While this rapid effect was 
found to be non-classical, prolonged GC exposure also increased the frequency of mEPSCs in a 
manner that was sensitive to protein synthesis inhibitors, and was therefore a genomic/classical 
effect (Karst et al. 2010).  Similarly, in the anterior pituitary, GR activation lead to a decrease in 
ACTH release within 1 min that was sustained two hours after the GC administration 
(Groeneweg et al. 2011).  The former effect was shown to be non-classical and dependent on the 
rapid phosphorylation and membrane translocation of annexin-1, whereas the latter was found to 
be a genomic effect dependent on protein synthesis (Solito et al. 2003; Groeneweg et al.).  A 
second general principle is that the presence of GR (or MR) on the cell surface provides a strong 
indication for a role for non-classical hormone signaling.  A final general principle of rapid non-
classical GR signaling is that GC stimulation often acts in a “permissive” manner (Groeneweg et 
al. 2011).  That is, the rapid effects of GCs tend to alter pre-existing activity or the threshold of 
activity of neurotransmitters and/or ion channels rather than inducing or inhibiting function in an 
all or none fashion.  These insights, as well as knowledge of non-classical signaling from other 
hormone receptors (such as ER) provide a strong foundation from which to explore whether non-
classical GR signaling operates in other neurological systems, particularly during 
neurodevelopment where rapid GC action remains highly unexplored. 
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1.3 GR: ROLES IN NEURODEVELOPMENT 
GR is known to play a role during neurodevelopment.  GR expression begins at around 
embryonic day 10 (E10) in mice and GC synthesis is detectable by E14 (Reichardt and Schutz 
1996).  GR mutant mice in which receptor function is deficient have been used to demonstrate 
that decreased function of the receptor leads to increased mRNA expression of the ACTH 
precursor proopiomelanocortin (POMC) in the anterior pituitary and increased mRNA 
expression of CRH in the hypothalamus by E16.5 (Reichardt and Schutz 1996).  This suggests 
that a functional GR is necessary prenatally for the establishment of proper negative feedback 
loops in the HPA axis. This finding has been strengthened by more recent analyses using a GR 
conditional knockout mouse where Cre recombinase was under the control of a CamKIIα 
promoter.  This led to a loss of GR in neurons and glial cells in the developing brain (including 
in the pituitary gland) and over a 750-fold increase in the expression of plasma corticosterone 
and a 16-fold increase in plasma ACTH.  These mice did not survive past postnatal day 10 
(Erdmann et al. 2008).  The effects of prenatal HPA axis disorders are thought to have effects on 
physiology and behavior that extend beyond the prenatal period.  For example, dysregulation of 
the HPA axis prenatally is hypothesized to contribute to mood disorders and other psychiatric 
conditions such as schizophrenia later in life (Reichardt and Schutz 1996).  
1.3.1 Prenatal Stress 
The importance of regulating GR activity during fetal development is also demonstrated by the 
high level of 11β-HSD2 expression in the placenta as well as in the fetal brain beginning at mid-
gestation (Holmes et al. 2003).  One implication of this finding is that high levels of GC, 
  13 
including in the developing brain, may have deleterious effects on fetal development.  This may 
be prevented by 11β-HSD2 expression.  Therefore, many studies have focused on the effect of 
“prenatal stress” or exogenous antenatal GC administration on neurodevelopment (Glover et al. 
2009).  Specifically, these studies aimed to understand the effect of supraphysiologic GC levels 
(levels sufficient to overwhelm or bypass 11β-HSD2) on fetal brain development.  Although 
there is some variability in outcomes, both human and animal studies of prenatal stress suggest 
that exposure of fetuses to abnormally elevated levels of GCs leads to an increase in the stress 
response postnatally and generally deleterious effects on neurodevelopment (Glover et al. 2009).  
For example, exposing female non-human primates to unpredictable noise during pregnancy led 
to a reduced volume of the hippocampus in offspring (Coe et al. 2003).  Rodents exposed to 
prenatal stress produced offspring with lower levels of both GC receptors (i.e. MR and GR) 
(Glover et al. 2009).  The decrease in MR and GR may partly explain the heightened stress 
response in offspring of mothers exposed to prenatal stress since feedback inhibition is a critical 
source of regulation of the HPA axis.   
While prenatal stress can have a number of physiological effects on the pregnant mother 
and her offspring, the importance of GC activity in producing some of the observed effects in the 
CNS has been strengthened by experiments using adrenalectomized dams.  Since the adrenal 
glands produce GC hormones, adrenalectomy prevents GC release.  Barbazanges et al. showed 
that the pups of adrenalectomized dams subject to prenatal stress did not show the decrease in 
hippocampal GR levels seen in pups from dams with intact adrenals or in pups from 
adrenalectomized dams given corticosterone injections (Barbazanges et al. 1996). 
The results of human clinical studies of pregnant mothers exposed to prenatal stressors 
are varied, but prenatal stress has been commonly associated with an increased incidence in  
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childhood attention deficit hyperactivity disorder (ADHD)(Glover et al. 2009).  A general 
increase in anxiety, decreased cognitive development, and delayed language development are 
among the other outcomes in children of mothers exposed to prenatal stressors (Glover et al. 
2009). 
1.3.2 Exogenous Antenatal GC Administration 
Prenatal stress is also likely to involve other hormones in addition to GCs, so caution must be 
applied in ascribing neurodevelopmental defects to altered GR signaling alone.  A more direct 
method of identifying GR effects is through an examination of the clinical effects of exogenous 
GC administration.  Neurodevelopmental defects have also been observed when synthetic GCs, 
such as DEX or betamethasone, are administered exogenously to pregnant females in the absence 
of underlying prenatal stress.  This is a clinically relevant application since DEX and 
betamethasone are administered to pregnant mothers for the treatment of complications of 
prematurity and for congenital adrenal hyperplasia (CAH) (Yeh et al. 2004; Vos and Bruinse 
2010).  Antenatal exposure of pregnant rats to DEX led to decreased learning and memory in 
offspring and an increased sensitivity of the pups’ hippocampal and cortical neurons to injury 
following a toxic insult (Emgard et al. 2007).  Similarly, administration of DEX to pregnant rats 
led to impaired radial migration of neural progenitor cells in the embryos (Fukumoto et al. 2009).  
Taken in combination with the prenatal stress studies, this work strongly suggests that exposure 
of embryos to elevated GCs impairs CNS development and function and has negative effects 
postnatally on cognition and behavior.  The precise molecular mechanisms underlying these GC 
effects remain less clear, although there have been a number of important insights from recent in-
vitro and in-vivo studies that will be described below. 
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1.3.3 GR: Cellular Effects 
At the cellular level, GCs have been shown to affect both the proliferation and differentiation of 
cells in the developing CNS (Sabolek et al. 2006; Sundberg et al. 2006).  Alteration of the pattern 
of cell differentiation commonly results from GC treatment.  For example, exposure of rat neural 
progenitor cells (NPCs) to a high dose of DEX (10uM) was shown to decrease astroglial 
differentiation (Sabolek et al. 2006).  Similarly, DEX exposure of a neuroblastoma cell line 
resulted in increased differentiation into neuroendocrine cells (Ross et al. 2002).  In-vivo and in-
vitro studies by Sundberg and colleagues demonstrated that exposure to GCs decreased NPC 
proliferation by reducing the levels of the cell cycle protein cyclin D1 (Sundberg et al. 2006).   
The detrimental effects of GC exposure on NPC proliferation have also been 
demonstrated in the context of adult neurogenesis.  The subgranular zone is one of the major 
sites of adult neurogenesis.  Chronic stress and/or GC administration has been shown to 
significantly decrease neurogenesis in the subgranular zone of the adult rat hippocampus 
(Schoenfeld and Gould 2011). In contrast, adrenalectomy in adult rats resulted in increased 
neurogenesis of subgranular neurons (Schoenfeld and Gould 2011).  GC-mediated decreases in 
NPC proliferation and alteration of differentiation may account for some of the observed 
behavioral and neuro-developmental consequences of GC exposure.  The above studies provide 
some insights into mechanisms of GC action in the developing brain, but many aspects of NPC 
response to these hormones remain to be explored. 
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1.4 GC: CLINICAL USE AND CLINICAL EFFECTS 
Synthetic GCs such as DEX are used in various clinical contexts.  DEX administration is 
commonly used throughout pregnancy beginning at 5-6 weeks of gestation to mothers of 
children at high risk for congenital adrenal hyperplasia (CAH) (Vos and Bruinse 2010).  This is a 
condition marked by inadequate cortisol and aldosterone production, excess testosterone 
production, and resultant virilization of female fetuses (Hirvikoski et al. 2007).  In most cases, 
CAH is caused by a deficiency in the 21-hydroxylase enzyme, which is necessary for the 
production of both cortisol and aldosterone.  Cortisol is necessary for feedback inhibition at the 
pituitary gland.  Since pituitary signals also determine testosterone production, the lack of 
cortisol-mediated feedback inhibition leads to excess testosterone levels and virilization of 
female fetuses (Vos and Bruinse 2010).  DEX administration early in pregnancy inhibits 
pituitary-mediated production of testosterone and prevents virilization (Hirvikoski et al. 2007).   
DEX is also administered antenatally to accelerate heart and lung development in 
pregnancies at high risk for preterm delivery, and postnatally in the treatment and prevention of 
respiratory distress syndrome (Karlsson et al. 2000).  A widely cited study by Yeh et al. 
evaluated cognitive development in infants that were given DEX for the treatment of severe 
respiratory distress syndrome.  This was a double-blind placebo controlled study in which DEX 
was administered in a tapered dose for 28 days following premature birth.  The infants were 
given their first dose of DEX within 12hrs of birth and their neurological function and IQ was 
assessed between ages 7-9 years by a pediatric neurologist or a teacher (for IQ scores) who was 
blinded to the study design or the clinical history of the children.  Of the 262 infants that 
received treatment, 146 were evaluated at school age.  The clinical assessment indicated a variety 
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of negative neurobiological side effects of DEX including significantly decreased motor skills, 
significantly impaired motor coordination, and significantly decreased IQ (Yeh et al. 2004).    
In a separate study, decreased cortical folding was found on MRI in infants that received 
antenatal GCs (Modi et al. 2001).  Since CAH is a relatively rare condition, fewer data are 
available on the effects of DEX treatment on the neuro-development of these children.  Based on 
the available data, however, a number of clinical reviews express concern about the potential 
negative neurodevelopmental consequences of early prenatal DEX treatment, and at least one 
recent clinical assessment found decreases in verbal working memory, self-perception of 
scholastic competence, and increased self-rated social anxiety in 7-17 year olds that received 
antenatal DEX for CAH (Miller 1999; Modi et al. 2001; Hirvikoski et al. 2007).    
In adults, exposure to chronic levels of endogenous stress hormones such as the GC 
cortisol is associated with mood disorders and cognitive deficits that may be linked to hormone 
effects on cell proliferation (McEwen 2008).  Specifically, these illnesses have been partly 
attributed to GC inhibition of adult neural stem/progenitor (NSC/NPC) cell proliferation 
(Mirescu and Gould 2006).  One of two major sites of adult neurogenesis is in the dentate gyrus 
(DG) of the hippocampus. Chronic stress has been shown to lead to hippocampal atrophy that is 
also correlated with increased incidence of depression as well as deficits in learning and memory 
(McEwen 2004).  Stress-induced suppression of cell proliferation in the DG of the hippocampus 
has been observed in a number of different mammals, including rats and mice, in response to a 
variety of stressors including footshock, restraint stress, and predator odor (Mirescu and Gould 
2006).   
GCs have specifically been cited as important in the reduction of cell proliferation from 
these stress-inducing manipulations because adrenalectomy or blockade of HPA axis receptors 
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(such as CRF-1) increase cell proliferation (Mirescu and Gould 2006; Schoenfeld and Gould 
2011).  The inhibitory effect of GCs on DG cell proliferation is likely mediated through GR and 
not MR. Even though both of these GC receptors exist in the adult hippocampus, the high 
affinity MR is occupied under baseline (unstressed) levels of GC circulation, unlike GR (Mirescu 
and Gould 2006).  Furthermore, pharmacological blockade of GR in rats prevented the loss of 
cell proliferation produced by elevated corticosterone levels (Wong and Herbert 2005).  Based 
on these clinical findings, gaining a better understanding of the mechanisms that underlie GC 
effects on NPC proliferation has the potential to have far-reaching clinical implications for a 
number of diseases that affect both adults and children. 
One potential GC target that may impact NPC proliferation are intercellular channels 
termed gap junctions and the connexin proteins that constitute these channels.  Connexins have 
been previously shown to have effects on NPC proliferation and connexin expression and 
function may be altered by GR activity (Cheng et al. 2004).   
1.5 GAP JUNCTIONS AND THE GAP JUNCTION PROTEINS: GENERAL 
BIOLOGY 
Gap junctions form intercellular channels between adjacent cells that allow the passage of ions 
and molecules less than 1kD in size (Bruzzone and Dermietzel 2006).  Mammalian gap junctions 
are composed of connexin proteins, six of which make up a single connexon, or hemichannel 
(Bruzzone and Dermietzel 2006).  Two opposing hemichannels on adjacent cells, in turn, 
constitute a gap junction (Goodenough and Paul 2003)  (Figure 5). 
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Figure 5: Gap Junctions are Composed of Connexin Proteins  
Six individual connexin proteins combine to form a gap junction hemi-channel.  Two hemi-
channels from adjacent cells form a gap junction through which metabolites and small molecules 
less than 1kD in size can pass.  Connexin 43 gap junctions can be phosphorylated by ERK-1/2, 
and this phosphorylation leads to inhibition of gap junction intercellular communication (Laird 
2006). 
 
Over 20 connexin genes have been identified and classified according to predicted molecular 
weight. Furthermore, expression of the various connexins is highly tissue specific (Bruzzone and 
Dermietzel 2006).  The most ubiquitous and most extensively studied connexin is connexin 43 
(Cx43) (Laird 2006).  
Connexins are integral membrane proteins, which pass through the cell membrane four 
times. The connexin proteins have two extracellular loops and one intracellular loop with their N 
and C-termini exposed to the cytoplasm (Laird 2006).  These proteins have a relatively short 
lifespan, measured to be as short as 1hr, thus providing one potential mechanism whereby levels 
of gap junction intercellular communication (GJIC) can be rapidly modified (Laird 2006).  Most 
connexins are co-translationally inserted into the endoplasmic reticulum (ER) and have been 
reported to oligomerize in the ER as well (Laird 2006).  Following ER exit, connexins typically 
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pass through the cis-Golgi network and are then inserted into the plasma membrane where they 
diffuse inside lipid bilayers as connexons.  The formation of gap junctions appears to require 
association of connexons with N- and E- cadherins that allow for the docking of 
connexons/hemi-channels on adjacent cells into a functional gap junction (Laird 2006).   
Gap junction degradation generally begins with the internalization of double membrane 
vesicular structures called “annular junctions.” These structures are an internalized gap junction 
or part of a gap junction.  In some cases, such as has been demonstrated for Cx43, gap junctions 
may be internalized in smaller segments via clathrin coated pits or via a caveolin-dependent 
process.  Internalized plaques are usually subject to degradation in lysosomes.  However, while 
most connexin proteins leaving the plasma membrane are mono-ubiquitinated and subject to 
lysosomal degradation, there is also evidence suggesting that internalized connexin proteins are 
subjected to poly-ubiquitination and proteasomal degradation (Laird 2006). 
1.5.1 Gap Junctions: Post-Translational Modification by Phosphorylation 
Most connexins are subjected to post-translational modification by phosphorylation.  For 
example, the C-terminal domain of Cx43 has a number of sites that can be phosphorylated. In 
general, phosphorylation of Cx43 leads to inhibition of GJIC (Saez et al. 2003; Ai and Pogwizd 
2005).  Several kinases including Protein Kinase A (PKA), Protein Kinase C (PKC), Src, and 
MAPK have been shown to phosphorylate Cx43 (Solan and Lampe 2009).  Phosphorylation of 
Cx43 leads to a change in the electrophoretic migration of the protein through SDS/PAGE gels.  
In the absence of phosphorylation, or when cell lysates are subject to alkaline phosphatase 
treatment, only a single “P0” band is detected.  The slower migrating “P1” and “P2” bands are 
likely to be phospho-isoforms of Cx43.  The electrophoretic isoforms are thought to be a product 
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of both the additional mass of phosphorylation (80Da) as well as conformational changes in the 
protein that resist denaturation even under SDS-PAGE conditions (Solan and Lampe 2009).   
The effect of phosphorylation on Cx43 is highly dependent on the specific kinase 
responsible for the phosphorylation and, in turn, the specific site of phosphorylation (Solan and 
Lampe 2009).  For example, PKA enhances Cx43 delivery to the plasma membrane and gap 
junction plaque assembly, whereas PKC phosphorylation at serine 262 inhibits cell cycle 
progression of proliferating cardiomyocytes (Paulson et al. 2000; Doble et al. 2004).  ERK-1/2, a 
member of the MAPK family, is an important regulator of Cx43 phosphorylation and has 
specifically been shown to inhibit GJIC following phosphorylation of serines 279, 282, and 255 
on the Cx43 protein (Warn-Cramer et al. 1998).  Other major regulators of Cx43 phosphorylation 
include the protein serine/threonine phosphatases (PSTPs) such as protein phosphatases 1 (PP1) 
and 2A (PP2A) (Cruciani et al. 1999; Saez et al. 2003; Ai and Pogwizd 2005).  Cx26, unlike 
most other gap junction proteins, is not known to be modified by phosphorylation.   Regulation 
of its function may therefore be mediated at the level of gene expression. In fact, one report 
demonstrated that Cx26 is transcriptionally upregulated by GCs (Kojima et al. 1995). 
1.5.2 Gap Junctions: Expression in the CNS 
Of the 20 connexin subtypes identified, at least five connexins are known to be expressed in the 
rodent cerebral cortex (Bruzzone and Dermietzel 2006; Elias and Kriegstein 2008).  While there 
are clear temporal and spatial variations in the expression of connexin isoforms within the CNS, 
both Cx43 and Cx26 are localized to proliferating and undifferentiated neurons (Nadarajah et al. 
1997; Bruzzone and Dermietzel 2006).  Specifically, Cx26 is expressed throughout the 
developing rodent brain from the ventricular zone, through the intermediate zone and up to the 
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cortical plate, whereas Cx43 is most highly expressed in the ventricular zone and is highly 
expressed in-vitro in NPC cultures (Nadarajah et al. 1997; Cheng et al. 2004; Elias et al. 2007). 
 In the adult brain, Cx36 is the most abundantly expressed connexin in neurons.  Cx26, 
Cx43, and Cx30 are all expressed in astrocytes, and Cxs 29, 32, and 47 are expressed in 
oligodendocytes (Connors and Long 2004).  Cx36 has been found to play an important role in 
electrical gap junction coupling in adult CNS neurons.  The physiological importance of gap 
junction mediated coupling in neurons was primarily thought to involve the maintenance of 
subthreshold spiking among groups of neurons (Connors and Long 2004).  More recent findings 
have suggested that gap junction electrical synapses have specific effects on behavior, such as 
contributing to fear learning and memory in rats (Bissiere et al. 2011).  In contrast to neurons, the 
precise role of gap junctions in normal physiology in astrocytes and oligodendrocytes is 
controversial, but the passage of Ca2+ currents, buffering of K+, and the intercellular passage of 
other small metabolites such as ATP remain the favored theories (Orthmann-Murphy et al. 
2008). 
1.5.3 Gap Junctions and NPC Proliferation 
Gap junctions and their constituent connexin proteins may play a number of important roles in 
the development of the embryonic brain (Bruzzone and Dermietzel 2006; Elias and Kriegstein 
2008).  Gap junction coupling has been demonstrated during most stages of embryonic cortical 
development and remains prominent during the early postnatal period as well (Bittman et al. 
2002).  Pharmacologic disruption of GJIC in neural progenitors has been shown to decrease the 
rate of proliferation and prevent cells from entering the cell cycle (Bittman et al. 2002).  
Inhibition of Cx43 gap junctions in in-vitro NPC culture led to decreased proliferation and 
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increased differentiation of these cells.  In addition, NPCs remained in a proliferative state 
following basic fibroblast growth factor (bFGF) withdrawal if Cx43 was simultaneously 
overexpressed, indicating that Cx43 mediated GJIC may be necessary for NPC proliferation  
(Cheng et al. 2004).   
The specific mechanism whereby gap junctions facilitate NPC proliferation remains an 
active area of investigation.  One area of focus has been the role of gap junctions and 
hemichannels in the propagation of Ca2+.  Intercellular Ca2+ signaling was significantly 
decreased following pharmacological inhibition of GJIC in coupled HEK293 cells (Toyofuku et 
al. 1998).  In addition, the propagation of spontaneous Ca2+waves through a Cx43 hemichannel-
dependent process was shown to be necessary for the proliferation of radial glial cells in the 
embryonic ventricular zone (Weissman et al. 2004). In addition, gap junction-mediated passage 
of small molecules such as cAMP or cell cycle proteins have also been posited to influence cell 
proliferation (Huang et al. 1999; Tabernero et al. 2006).   More recent work has also suggested 
that Cx26 and Cx43 may act as adhesive proteins facilitating radial glial migration during 
embryonic cortical development (Elias et al. 2007).  According to these studies, decreased cell 
numbers that are observed following gap junction inhibition or knockout during cortical 
development may be partly explained by connexin-dependent deficiencies in progenitor cell 
migration.  Observations from human diseases resulting from mutations in connexins have also 
been instructive in illustrating the potential role of these proteins in proliferation.      
1.5.4 Gap Junctions in Disease: Oculodentodigital Dysplasia 
Mutations in various connexins are associated with at least eight human diseases (Laird 2006).  
The only human disease associated with a Cx43 mutation, which is the most ubiquitous and 
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extensively studied connexin, is ococulodentodigital dysplasia (ODDD). At least 28 different 
mutations in the Cx43 gene have been associated with ODDD (Laird 2006). Patients suffering 
from this autosomal dominant mutation have a combination of brittle nails, hair abnormalities, 
conductive hearing loss, lens defects, corneal defects, abnormalities of the teeth, and variable 
neurological and cardiovascular abnormalities (Loddenkemper et al. 2002; Laird 2006).  The 
neurological symptoms of ODDD include motor disorders (in particular spasticity) autonomic 
dysregulation, bladder control issues, cranial nerve abnormalities, and some cases of mental 
retardation or reduced intelligence (Loddenkemper et al. 2002).  In addition, subcortical white 
matter lesions and basal ganglia changes have been reported on MRI from ODDD patients 
(Loddenkemper et al. 2002).   
In-vitro analysis of two mutant Cx43 variants associated with ODDD revealed that 
mutant Cx43-expressing cells form gap junctions that lack GJIC as measured by Lucifer yellow 
dye coupling (Roscoe et al. 2005).  In addition, co-expression of WT and mutant Cx43 revealed 
that the mutant protein acts in a dominant negative fashion and down-regulates GJIC (Roscoe et 
al. 2005).  The loss of GJIC has also been shown in a mouse model of ODDD where GJIC in 
granulosa cells from these mice showed an 80-90% reduction in GJIC compared to WT cells 
(Flenniken et al. 2005).   
Aspects of these neurological findings are further corroborated by a Cx43 conditional 
knockout (cKO) mouse.  This cKO mouse, termed “Shuffler” due to characteristic abnormal gait 
and ataxia reminiscent of the ODDD phentoype, has Cre recombinase driven by a GFAP 
promoter leading to loss of Cx43 in premitotic radial glial cells and mature astrocytes  
(Wiencken-Barger et al. 2007).  The shuffler mouse was found to have disorganization and 
decreased size of the cortex, cerebellum, and hippocampus, as well disorganization of the 
  25 
ventricular and subventricular zones (Wiencken-Barger et al. 2007).  The findings from the 
Shuffler mouse suggest that defects in neural progenitor proliferation and/or migration may 
account for some of the phenotypic abnormalities seen in the adult animal. 
Taken in combination with the literature on GR, there is therefore a substantial body of 
evidence suggesting that connexin proteins and GR can modulate cell proliferation.  The proteins 
and signaling cascades that link GR and connexins to cell proliferation are, however, less well 
defined.  One protein that may play a critical role in the facilitating GR and connexin crosstalk is 
caveolin-1. 
1.6 CAVEOLAE AND CAVEOLIN-1 
Caveolae are specialized membrane invaginations localized to sphingolipid-rich domains called 
lipid rafts (Langlois et al. 2008).  Caveolae have a role in diverse cellular functions including 
endocytosis, transcytosis, calcium signaling, and the facilitation of various signal transduction 
pathways (Parton and Simons 2007).  The major proteins that constitute caveolae are caveolins.  
There are three isoforms of caveolin (cav) in mammalian cells (cav-1, 2, and 3) (Quest et al. 
2004). Caveolins are membrane proteins with N and C termini in the cytoplasm and a hairpin 
intermembrane domain (Parton and Simons 2007).  Cav-1/cav-2 caveolae form following 
oligomerization of the caveolins and association with cholesterol in lipid rafts (Parton and 
Simons 2007).   
Cav-1 and cav-2 are typically co-expressed in various tissues, whereas cav-3 is expressed 
in a homomeric form and is usually limited to muscle cells (Quest et al. 2004).  Despite co-
expression of cav-1 & 2 in most contexts, a cav-2 knockout (KO) in mice has few physiological 
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effects and does not alter the morphology or number of caveolae (Quest et al. 2004).  In contrast, 
a cav-1 KO leads to a complete loss of caveolae formation in tissues expressing cav-1/cav-2 and 
to more profound pathophysiological changes in many tissues (Quest et al. 2004; Jasmin et al. 
2009).  For example, cav-1 KO mice exhibit cardiac hypertrophy most likely through activation 
of MAPK signaling, defects in angiogenesis including reduced blood vessel density and 
incompletely formed capillaries, microvascular hyperpermeability due to defects in tight 
junctions and in the attachment of endothelial cells to the basement membrane, and reduced 
lifespan (Hnasko and Lisanti 2003).  
1.6.1 Caveolins: Roles in Signal Transduction 
Caveolins are thought to play a central role in signal transduction pathways originating from the 
cell surface  (Parton and Simons 2007).  For example, cav-1 has been proposed to act in an anti-
proliferative manner in CHO cells by down-regulating ERK-1/2 signaling (Quest et al. 2004).  
Along the same lines, knockdown of cav-1 was shown to increase ERK-1/2 activity and induce 
tumorogenecity in NIH-3T3 cells (Galbiati et al. 1998).  Caveolin-1 has also been shown to limit 
cellular proliferation by other mechanisms such as sequestering β-catenin to the plasma 
membrane thereby preventing the transcription of pro-proliferative genes such as cyclin D1 
(Quest et al. 2004).  While in most contexts cav-1 expression is associated with decreased 
proliferation, cav-1 was shown to enhance cell survival and proliferation of prostate cancer cells 
(Li et al. 2009).   
The precise mechanisms whereby cav-1 expression can be pro-proliferative in one 
context but anti-proliferative in another remain unclear. However, cav-1 may play a role in 
intercellular signaling through effects on GJIC (Langlois et al. 2008; Matthews et al. 2008).  
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Specifically, cav-1 has been found to co-immunoprecipitate with Cx43, and overexpression of 
cav-1 has been shown to increase GJIC (Matthews et al. 2008). 
1.6.2 Caveolins: Cav-1 and Steroid Hormone Receptors 
Cav-1 has also been implicated in signal transduction pathways involving steroid hormone 
receptors.  The most well established case involves the facilitation of membrane ER signaling.  
In this case, immunoprecipitation studies established an association between cav-1 and ERα. 
Furthermore, biochemical fractionation and indirect immunofluorescence studies revealed the 
presence of ERα within the plasma membrane (Razandi et al. 2002).  In addition, over-
expression of cav-1, and in particular the cav-1 scaffolding domain, increased ERα membrane 
localization, suggesting that cav-1 expression directs membrane localization of the ER (Razandi 
et al. 2002).   
Serine 522 in the E-domain of ERα was found to be particularly important for association 
with cav-1.  Mutation of this serine to alanine reduced cav-1 association with ERα by 60%, but 
had no effects on nuclear localization or transcriptional activity of the receptor.  In contrast, 
mutations in the A/B or C domains of ERα had no effects on association of the receptor with 
cav-1 (Razandi et al. 2003).   Interestingly, E2 stimulation decreased ERα association with cav-1 
in MCF-7 breast cancer cells, but increased this association in vascular smooth muscle cells, 
providing a potential mechanism to explain how cav-1 expression may have differential effects 
in different cell types (Razandi et al. 2002).   
More recently, exploration of membrane localized GR has revealed similar patterns of 
association with cav-1.  In particular, GR and c-src were found to co-localize to cav-1 enriched 
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membrane fractions in A549 lung epithelial cells and knockdown of cav-1 was shown to limit a 
GC and c-src dependent non-classical GR signaling mechanism (Matthews et al. 2008).  In 
particular, cav-1 knockdown prevented GR dependent activation of protein kinase B and reduced 
GR-mediated inhibition of cell proliferation (Matthews et al. 2008). Taken together with cav-1’s 
potential involvement in GJIC (see above), these findings suggest a potential, and heretofore 
unexplored, molecular mechanism whereby non-classical GR actions may be coupled to 
downregulation of GJIC via a cav-1 dependent process. 
According to this hypothesis, cav-1 links GR action to connexin through its role as a 
structural protein that maintains caveolae-containing lipid rafts.  However, this does not explain 
how GR activation alters connexin proteins.  One signaling cascade that may link GR and 
connexin in a cav-1 dependent manner is the ERK-1/2 pathway.   
1.7 ERK-1/2 SIGNALING: BASIC BIOLOGY 
ERK-1/2 belongs to the MAPK family and is a key part of a cellular signaling cascade that 
transmits signals from the cell surface to the nucleus (Seger and Krebs 1995; Galabova-Kovacs 
et al. 2006).  The general scheme of signal transduction leading to ERK-1/2 activation (i.e., 
phosphorylation) begins when cell surface signaling, typically from growth factor receptors, 
initiates the small G protein Ras (Seger and Krebs 1995) (Figure 6). 
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Figure 6: Schematic of an ERK-1/2 Activation Pathway 
ERK-1/2 activation may occur in response to a diverse array of upstream signals and can be 
regulated by the interaction of a number of kinases and phosphatases.  Figure 6 illustrates a 
simplified version of one activation pathway.  The small G-protein Ras is activated into Ras-
GTP by cell surface signaling.  Ras binds to and activates Raf.  Phosphorylation of certain Raf 
isoforms by kinases such as the c-src family as well as dephosphorylation by phosphatases such 
as PP2A aid in its activation.  Activated Raf phosphorylates and activates MEK, which then 
phosphorylates and activates ERK (McCubrey et al. 2007). 
 
Ras is able to activate a number of signaling pathways including Raf/MEK/ERK, PI3K/Akt, and 
RalEGF/Ral (McCubrey et al. 2007).   
There are four Ras proteins and they each have varying abilities to activate the three 
downstream signaling cascades outlined above, with the K-Ras subtype of Ras thought to be the 
stronger activator of the Raf/MEK/ERK pathway (McCubrey et al. 2007).   Either farnesylation 
or geranylgeranylation at a cysteine residue on Ras are necessary for its recruitment to the 
plasma membrane and subsequent activation.  Upon activation by growth factors, mitogens, or 
cytokines, active Ras recruits Raf from the cytoplasmic compartment to the cell membrane 
(Galabova-Kovacs et al. 2006).   
The Raf proteins, which consist of A-Raf, B-Raf, and C-Raf (or Raf-1) are 
serine/threonine kinases which contain a number of regulatory phosphorylation sites.  
Recruitment by Ras, dimerization, and phosphorylation/dephosphorylation on various sites are 
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all key events in activation of Raf (McCubrey et al. 2007).  In particular, dephosphorylation at 
serine 259 by PP2A and phosphorylation at tyrosines 340 and 341 by Src family kinases are key 
in Raf activation (Chang et al. 2003).  Activated Raf phosphorylates the S/T dual-specificity 
mitogen activated protein kinase/ERK kinase (MEK) on serine residues in the MEK catalytic 
domain (McCubrey et al. 2007).  MEK, in turn, phosphorylates and activates ERK-1/2 
(Galabova-Kovacs et al. 2006).   
1.7.1 ERK-1/2 Signaling: Downstream Targets and Effects 
Once activated, the Ras/Raf/MEK/ERK pathway has a number of downstream targets and 
consequently has been shown to have wide ranging effects on cell physiology including 
modulation of cell proliferation, migration, survival, and differentiation (Galabova-Kovacs et al. 
2006).  Proliferation is a particularly common outcome from Ras/Raf/MEK/ERK signaling and, 
in fact, constitutive activity of Ras proteins has been found in around 30% of human cancers 
(Chang et al. 2003).  Interestingly, there are also some instances where Ras activity has been 
shown to have anti-proliferative activity (McCubrey et al. 2007).  One explanation for this 
difference may be that different Raf proteins activated by Ras activate different targets.  For 
example, transfecting NIH-3T3 cells with A-Raf led to cyclin D1 up-regulation and an increase 
in proliferation.  In contrast, transfection of NIH-3T3 cells with B-Raf led to induction of p21 
and G1 arrest (Chang et al. 2003). 
In addition to direct effects of Raf on cell proliferation, activated ERK-1/2 itself 
phosphorylates and activates targets such as the transcription factors Ets-1, AP-1, c-Myc, NF-kB, 
and CREB, all of which can have effects on cell proliferation (Chang et al. 2003).  A number of 
these ERK-1/2 targets induce pro-proliferative genes such as cyclins and cyclin dependent 
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kinases.  For example, CREB, Ets-1, and AP-1 all have been shown to directly or indirectly lead 
to increased expression of the pro-proliferative gene, cyclin-D1 (McCubrey et al. 2007).  
However, in some cases these transcription factors may also inhibit proliferation by inducing 
genes such as p21 that can cause cell cycle arrest (Chang et al. 2003).  In the specific case of 
neural progenitor/stem cells, the available evidence also suggests that ERK-1/2 can act in a pro-
or anti-proliferative (pro-differentiation/pro-apoptotic) manner.  For example, fibroblast growth 
factor-2 (FGF-2) dependent proliferation of adult NPCs was shown to depend on ERK-1/2 
mediated up-regulation of cyclin D1 (Kalluri et al. 2007).  Similarly, the insulin like growth 
factor-1 (IGF-1) mediated proliferation of oligodendrocyte progenitor cells was shown to depend 
on ERK-1/2 activation (Cui and Almazan 2007).   
ERK-1/2 activation has also been shown to be important for the differentiation of NPCs. 
For example, an increase in ERK-1/2 activity correlated with bone morphogenic protein 4 
(BMP4) mediated differentiation of rat NPCs (Moon et al. 2009). In the context of mature 
neurons, ERK-1/2 activation has been shown to act as a pro-apoptotic factor.  ERK-1/2 
activation has also been shown to increase neuronal cell death, such as in the context of oxidative 
stress (Levinthal and Defranco 2005).  Taken together, these findings suggest that the 
Ras/Raf/MEK/ERK pathway, and more specifically ERK-1/2, has a highly context and cell-type 
dependent role in proliferation.     
1.7.2 ERK Signaling: GR and Gap Junctions 
A more recently identified target of ERK-1/2 that may also have potential effects on NPC 
survival and/or proliferation is the Cx43 protein.  In particular, serines 279, 282, and 255 
(S279/S282) and (S255) in the carboxyl tail of Cx43 have been identified as consensus ERK-1/2 
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target sites (Warn-Cramer et al. 1998; Cameron et al. 2003).  Phosphorylation of Cx43 
S279/S282 and S255 was shown to down regulate GJIC (Warn-Cramer et al. 1998).  In light of 
the previously described relationship between changes in GJIC and effects on cell proliferation, 
examining ERK-1/2 effects on Cx43 phosphorylation may potentially provide unique insights 
into cell cycle progression in GC-exposed NPCs.  Interestingly, GR has been shown to rapidly 
activate ERK-1/2, providing a potential mechanism linking GC stimulation to modulation of 
GJIC and cell proliferation (Qiu et al. 2001; Cato et al. 2002). 
1.8 DEX TREATED PRIMARY NEURAL PROGENITORS AS A MODEL SYSTEM 
FOR GC EFFECTS ON GJIC AND CELL PROLIFERATION 
In order to experimentally determine the nature of the interaction of GR and GJIC in the context 
of neurodevelopment, and to precisely characterize the potential role of cav-1 and ERK-1/2 in 
this process, we needed an appropriate model system.  DEX treated primary NPCs were highly 
suitable for this task. 
Embryonic day 14 (E14) derived primary mouse NPCs are an ideal platform for studying 
the role of connexin proteins in proliferation and their regulation by GCs.  The Cx43 protein is 
expressed in embryonic derived NPCs, and we have demonstrated the presence of both Cx43 and 
Cx26 in our NPC cultures (i.e., neurospheres) (Cheng et al. 2004).  In addition, GR is expressed 
in the embryonic brain prior to E14 and is also expressed in the primary NPCs used in our 
laboratory (Reichardt and Schutz 1996). It has been previously shown that DEX administration 
limits primary NPC proliferation in a GR-dependent fashion (Sundberg et al. 2006).  This system 
therefore expresses all of the critical cellular components we were interested in studying and is 
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capable of recapitulating the primary physiological effect of hormone exposure (i.e., decreased 
proliferation) that we want to study.  In addition, an in-vitro system is highly manipulable and 
allows us to easily use a combination of imaging techniques such as FRAP, biochemical 
techniques such as Western blot, and molecular biological techniques such as qRT-PCR.  
1.9 DISSERTATION GOALS 
The major objectives of the work presented in this thesis are as follows: (1) to understand the 
effects of a transient GC exposure on neural progenitor cell gap junction intercellular 
communication, (2) to explain the molecular mechanism whereby a transient hormone exposure 
could affect GJIC, and (3) to determine the impact of this brief GC exposure on cell physiology.  
I was motivated to pursue these objectives based on a number of previous studies (referenced in 
my introduction) that provided the following important insights: First, that GC exposure limits 
NPC proliferation in-vitro and in-vivo.  Second, that changes in connexins and GJIC can, in turn, 
modulate the proliferation of NPCs and other cell types in-vitro. Third, that transient GC 
exposure activates signaling cascades, including the MAPK pathway, and that these signaling 
cascades can impact connexin protein and GJIC.  Fourth, and finally, that human clinical studies 
suggest that antenatal or postnatal exposure to synthetic GCs such as DEX may have adverse 
consequences on neurodevelopment.  Based on these findings, I hypothesized that a transient GC 
exposure would limit GJIC, and that this reduction in intercellular communication would, in turn, 
reduce cell proliferation.   
To test these hypotheses I first adapted the gap-FRAP method for measuring GJIC in 
neurospheres.   These studies revealed that a 1hr DEX exposure significantly reduced GJIC in 
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NPCs in a GR-dependent manner, and comprised the fundamental physiological observation that 
motivated my subsequent studies.  The majority of the experiments that followed were aimed at 
understanding the molecular basis for this loss of GJIC.  I focused my studies on the expression 
and phosphorylation of the connexin proteins that constitute gap junctions and potential signaling 
cascades that could lead to rapid alterations in connexins, and, as a result, GJIC.  Finally, in order 
to understand the broader consequence of a reduction in GJIC on NPC physiology, I examined 
the effect of a transient loss in GJIC on subsequent NPC proliferation.  These studies have 
revealed a non-classical GR-mediated mechanism with rapid GC effects on GJIC that is 
mediated by site-specific, MAPK-dependent phosphorylation of Cx43 with subsequent alteration 
of NPC proliferation. 
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2.0  EXPERIMENTAL PROCEDURES 
2.1 MOUSE NEURAL PROGENITOR CELL CULTURE 
Mouse NPCs were prepared according to the technical manual provided by StemCell 
Technologies (StemCell Technologies, Vancouver, Canada). E14.5 embryos were obtained from 
pregnant C57Bl/6J (for Cav-1 KO) or CD1 mice.  The Cav-1 KO animals were a generous gift 
from Dr. Ferruccio Galbiati (University of Pittsburgh, Department of Pharmacology, Pittsburgh, 
PA, USA).  Pup brains were removed from the embryos, cortical lobes separated and the 
meninges removed.  The tissue was disrupted by trituration and filtered through a 70µM mesh. 
1x105 cells/mL were plated on a 10cm Petri dish in 10mL of StemCell Technologies 
Proliferation Medium containing 20ng/mL recombinant human epidermal growth factor, 
10ng/mL recombinant human fibroblast growth factor, and 2ug/mL heparin.  Neurospheres that 
formed were passaged approximately every 4-5 days.  For passaging, cells were collected by 
centrifugation for 5min at 500rpm, disassociated by pipetting 25X using a P200 pipette set at 
100uL, and replated at 1x105 cells/mL in fresh proliferation media containing all supplements.  
Cells were used between passages 2-6.  The use of animals was approved and was in compliance 
with the guidelines of the Institutional Animal Care and Use Committee (IACUC) of the 
University of Pittsburgh.   
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2.2 WESTERN BLOT ANALYSIS 
20-100ug of total protein from cell lysates (collected in 10mM TRIS -pH 8.0, 1mM EDTA, 
0.5mM EGTA, 140mM NaCl, 1% Triton X-100, 1mM PMSF, 0.1% Na-deoxycholate, and 0.1% 
SDS) were subject to SDS-PAGE, transferred to a polyvinylidene fluoride (PVDF) membrane 
and probed with the appropriate primary antibody (Ab) and peroxidase conjugated secondary 
Ab.  For isolation of Triton X-100 insoluble fractions, cells were lysed by a 30min incubation in 
1% Triton X-100, 1mM EDTA and protease inhibitor in ice-cold Tris-buffered saline (TBS) 
followed by 30min centrifugation at 16.1 rcf.  All blots were probed with primary Ab. at a 1:300 
concentration and diluted in .1% BSA in PBST (.2% Tween) solution.  The SNAP i.d. blotting 
system was used for all Western blots (Milipore, Temecula, CA).   Primary Abs used for 
Western blot analysis include rabbit anti-Cx43, rabbit total ERK-1/2, mouse phospho-ERK-1/2 
(Cell Signaling, Danvers, MA), mouse anti-Cx26 (Invitrogen, Carlsbad, CA), rabbit anti-
phospho-Cx43 at serine 279/serine282, rabbit anti-phospho-Cx43 at serine 255, anti-GR (P20), 
anti-Cav-1 (N20) and goat anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA).  Secondary 
Abs were goat anti-mouse or anti rabbit HRP conjugate or a donkey anti-goat HRP conjugate 
(Bio-Rad, Hercules, CA).  Secondary Abs were used at 1:1000 in .1% BSA in PBST.  Proteins 
were visualized using a chemiluminescence visualization system (Perkinelmer, Shelton, CT). 
Images were quantified (densitometry) using NIH ImageJ software (ImageJ, 
http://rsbweb.nih.gov/ij/).   
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2.3 SUCROSE GRADIENT FRACTIONATION 
NPC were washed 2X in ice cold phosphate-buffered saline (PBS) and placed in 2mL of a MES 
buffer (0.01M MES pH 6.5, 0.15M NaCl, and 1% (v/v) Triton X-100).  Cells were homogenized 
using a loose fitting Dounce homogenizer and passing the glass tube 10X.  The homogenate was 
adjusted to 40% sucrose by the addition of 2mL of 80% sucrose prepared in MES buffer and 
placed at the bottom of an ultracentrifuge tube. A 5-30% linear sucrose gradient was formed 
above the homogenate and centrifuged at 39,000 rpm at 4°C for 17hrs in a SW41 rotor 
(Beckman Instruments). Fractions were carefully removed following centrifugation, combined 
into caveolin-enriched fractions (#4-6) and non-caveolin enriched fractions (#9-11) and analyzed 
by SDS-PAGE and Western blots. 
2.4 CO-IMMUNOPRECIPITATION 
The entire protocol was carried out at 4°C.  Cells were washed 2X in PBS and lysed in IP buffer 
containing 10mM Tris pH 8.0, 0.15 M NaCl, 5mM EDTA, 1% Triton X-100, 60mM octyl 
glucoside, and protease inhibitors.  Samples were put on rotation for 45 minutes at 4°C.  Soluble 
supernatant was precleared using protein A-Sepharose (10uL; slurry, 1:1) at 4°C.  Samples were 
centrifuged at 13,000 rpm for 10min and supernatant was taken and normalized for protein 
concentration.  One tenth of the volume was taken as an aliquot for total input.   The supernatant 
was incubated overnight with the particular antibody of interest and protein A-Sepharose (30uL; 
slurry, 1:1).  Beads were washed in lysis buffer 3 times on rotation for 10 minutes at 4°C.  The 
final wash was done with 2.5mM of Tris-HCl pH 7.5.  Beads were spun down at max speed for 
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1min and sample buffer was added and samples were boiled for 10min.  The supernatant was 
then subjected to Western blot analysis for GR and Cav-1 as detailed above.   
2.5 FRAP 
Mouse NPCs between passages 2-6 on 35mm MatTek glass bottom culture dishes were treated 
with 1ug/mL of Calcein AM 30 min prior to FRAP analysis (Invitrogen, Carlsbad, CA).  FRAP 
was conducted on an Olympus IX81 confocal microscope equipped with Fluoview data 
collection software. The photobleaching laser was set to 95% laser power for 1.8 seconds and 
recovery images captured every 40 seconds for 25 images. All data were quantified on open 
source NIH ImageJ software (ImageJ, http://rsbweb.nih.gov/ij/) and analyzed using GraphPad 
Prism software (GraphPad Software Inc, La Jolla, CA).  FRAP recovery curves were fit to an 
exponential decay equation present in the GraphPad menu, and t1/2 was tabulated by the software 
from this fit. 
2.6 CO-IIF AND 5-BROMO-2’DEOXYURIDINE LABELING 
10µM BrdU in 0.9% saline and 0.007M NaOH was added to NPCs 1hr prior to collection of 
cells.  NPCs were collected by light centrifugation in a 15mL conical tube, fixed in 4% 
paraformaldehyde in PBS. BrdU epitopes were exposed by treatment of cells with 2N HCl, 
which also served to permeabilize cells.  Cells were placed on glass coverslips for 30min in a 
37°C incubator and allowed to settle onto the coverslip.  Cells were then labeled with primary 
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and secondary antibodies using standard laboratory IIF conditions.  The primary antibodies used 
were mouse anti-BrdU (1:500) (Sigma Aldrich, St Louis, MO) and rabbit anti-Ki-67 (1:100) 
(Abcam, Cambridge, MA).  The secondary Abs included Alexa Fluor 488 goat anti-rabbit IgG 
(1:400) (Molecular Probes, Eugene, OR) or Cy3 conjugated goat anti-mouse IgG (1:400) 
(Jackson ImmunoResearch, West Grove, PA).  Cells were visualized using an Olympus IX81 
confocal microscope with Fluoview software (Olympus, Center Valley, PA). 
2.7 STATISTICAL ANALYSIS 
Statistical comparison was conducted by 1-way-analysis of variance (ANOVA).  Post hoc Tukey 
HSD or Bonferroni was used to determine within group differences.  A p<0.05 was considered 
statistically significant. 
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3.0  RESULTS 
3.1 INHIBITION OF GJIC FOLLOWING A BRIEF EXPOSURE TO GC 
NPCs from embryonic day 14.5 (E14.5) C57Bl/6 mice pups were utilized since they have the 
ability to differentiate into both glial and neuronal phenotypes in vivo and therefore provide a 
multipotent progenitor cell population. Furthermore, these NPCs are known to express Cx43-
containing gap junctions (Viti et al. 2003; Cheng et al. 2004), which may play a role in 
coordinating their synchronous passage through the cell cycle (Weissman et al. 2004).  NPCs 
were used between passages 2 and 10 to ensure enrichment of the NPC population (Jensen and 
Parmar 2006).  To determine functional effects of GCs on gap junctions, NPCs were subjected to 
a 1hr treatment with the synthetic GR agonist dexamethasone (DEX), a cell impermeable DEX 
conjugate (i.e. DEX-BSA), and/or the GR antagonist RU-486. GJIC was quantified using a 
fluorescence recovery after photobleaching (FRAP) assay.  FRAP (or gap-FRAP) is a well 
documented means of measuring GJIC that has high temporal resolution, is non-invasive, and 
uniquely, allows for precise determination of GJIC kinetics (Abbaci et al. 2008). The use of 
carbenexolone (Cbx), a gap junction inhibitor, confirmed that fluorescence recovery was 
specifically assessing GJIC. 
A 1hr exposure of NPCs to 100nM DEX resulted in a significant increase in the t1/2 of 
fluorescence recovery (Fig. 7 & Fig 8), which reflects an inhibition of GJIC.  Co-treatment with 
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1µM of the GR antagonist RU-486 prevented the DEX mediated reduction in GJIC (Fig 7 and 8) 
indicating that the rapid inhibitory effect of GCs on GJIC in NPCs is GR dependent.  All t1/2 
values were calculated by fitting a decaying exponential to the FRAP recovery curves (Fig. 7). 
 
 
Figure 7. FRAP: Fluorescence Recovery Curves for 1hr DEX Treatment 
NPCs preloaded with Calcein AM were subjected to the following 1 hr treatments; ethanol 
vehicle (Veh), 100nM DEX (+/- 1µM RU-486), RU-486 alone, and 200µM carbenoxolone 
(Cbx).  Fluorescence recovery within individual bleached cells in a representative experiment is 
shown in Fig 7. 
 
 
  42 
 
Figure 8: 1hr DEX Exposure Results in a Significant Increase in t1/2 
NPCs preloaded with Calcein AM were subjected to the following 1 hr treatments; ethanol 
vehicle (Veh), 100nM DEX (+/- 1µM RU-486), RU-486 alone, and 100nM DEX-BSA (+/- RU-
486). Mean values for t1/2 +SEM of recovery, are shown in Fig. 8. (n=4 independent experiments; 
1-way ANOVA, p<0.0001; post hoc Tukey’s Multiple Comparison Test, *=p<0.05). 
 
The relatively rapid onset of the hormone effect prompted us to consider whether DEX-
dependent inhibition of GJIC was mediated by non-classical GR action.  Since most GR-
dependent non-classical signaling mechanisms originate from activation of plasma membrane 
GR, a cell impermeable bovine serum albumin conjugated DEX (DEX-BSA) was utilized 
(Haller et al. 2008).  Interestingly, a 1hr exposure of NPCs to 100nM DEX-BSA led to a 
significant loss in GJIC that was comparable to that observed with DEX exposure.  In addition, 
co-treatment with 1µM RU-486 prevented the DEX-BSA mediated inhibition of GJIC (Fig 8).  
In combination, these results suggest that a GR-dependent non-classical signaling mechanism 
contributes to GC inhibition of GJIC in NPCs. 
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By measuring the fluorescence loss in all cells adjacent to the photobleached NPC, the 
number of NPCs connected to the photobleached NPCs can be tabulated. The t1/2 values in Fig 8 
were normalized to this number (Fig 9).  Some photobleached NPCs were not connected to any 
other NPCs via gap junctions (Fig. 9) and did not show fluorescence recovery.  The average 
number of cells connected to NPCs that recovered from photobleaching did not differ 
significantly between vehicle and hormone treated groups (Fig. 10). 
 
Figure 9: Number of NPCs Connected to NPCs Subject to FRAP 
NPCs were prepared from E14.5 mouse embryonic cortices.  Cultures preloaded with 
1ng/µLCalcein AM for 15min were exposed to 100nM DEX or 100nM DEX-BSA +/- 1µM RU-
486 where indicated for 1hr and GJIC measured using a gap-FRAP assay.  In order to determine 
the number of adjacent NPCs connected to the NPC subject to FRAP, fluorescence loss in 
adjacent NPCs was simultaneously measured together with the gain in fluorescence in the 
photobleached (i.e., subject to FRAP) NPC.  A loss in fluorescence in an adjacent NPC as the 
fluorescence increased in the photobleached NPC indicated a gap-junction mediated connection 
between the individual NPCs.  Resulting t1/2 values for fluorescence recovery were normalized to 
this value.  For all NPCs subject to FRAP, there were between 0-3 connected NPCs. 
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Figure 10: Average Number of NPCs Connected to FRAPPED NPC 
Among those NPCs that showed fluorescence recovery, there were no significant differences in 
the average number of connected NPCs 
 
3.2 BRIEF GC EXPOSURE LEADS TO RAPID PHOSPHORYLATION OF CX43 
A reduction in GJIC may result from post-translational modifications (e.g. phosphorylation) of 
connexins that constitute gap junctions and/or from a change in connexin gene expression 
(Moreno and Lau 2007; Solan and Lampe 2009). In fact, GC has been shown to induce 
connexin-26 (Cx26) expression in cultured rat hepatocytes (Kojima et al. 1995).  However, 
Western blot analysis failed to reveal effects of short term DEX exposure in NPC cultures on 
expression of total Cx26 and Cx43, two of the major connexin subtypes expressed in developing 
neuronal cells (Fig 11, 12, and 13).  Since the activity of Cx43 in gap junctions, but not Cx26, is 
regulated by its phosphorylation at multiple sites, Western blot analysis was used to examine 
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DEX effects on overall Cx43 phosphorylation.  As shown in Figures 12 and 14, a 1hr DEX 
treatment of NPCs led to an increase in expression of the slower migrating phosphorylated forms 
of Cx43 (i.e. P1 and P2) (Solan and Lampe 2009). In accordance with the results of gap-FRAP 
experiments (Fig 8 and 9), the DEX mediated increase in overall Cx43 phosphorylation was 
prevented by co-treatment with RU-486 and is therefore GR dependent.  Furthermore, Triton 
fractionation experiments examining the proportion of membrane Cx43 and non-membrane 
Cx43 did not reveal any significant differences following a 1hr DEX treatment (Fig 15 and 16), 
indicating that changes in membrane localization of Cx43 do not account for the reduction in 
GJIC. 
 
Figure 11: Cx26 Protein Levels Are Not Altered by 1hr DEX Exposure 
NPC total protein lysates subjected to the following 1 hr treatments; ethanol vehicle (Veh), 
100nM DEX (+/- 1µM RU-486), and RU-486 alone were analyzed by Western blot to determine 
Cx26 protein expression. Stripped blots were probed with an anti-actin antibody.  Fig. 11 is a 
single representative blot (n=3).  
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Figure 12: Cx43 Protein Expression Following a 1hr DEX Exposure 
NPC total protein lyates from cells treated for 1 hr with ethanol vehicle (Veh), 100nM DEX (+/- 
1µM RU-486), and RU-486 alone were subject to Western blot to determine Cx43 protein 
expression. Stripped blots were probed with an anti-actin antibody. P0, P1, and P2 in Fig 12 
indicate positions of unphosphorylated (P0) and phosphorylated forms (P1, P2) of Cx43.  Fig. 12 
is a single representative blot (n=4).  
 
 
Figure 13: Total Cx43 Levels Are Not Altered by 1hr DEX Exposure 
Fig 13 displays the mean +SEM of densitometric scans of multiple blots probed for total Cx43 
and normalized to Actin following a 1hr DEX exposure (n=4).  
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Figure 14: Cx43 Phosphorylation is Increased Following a 1hr DEX Exposure 
Fig 14 displays the mean +SEM of densitometric scans of multiple blots probed for 
phosphorylated Cx43 (P1+P2) and normalized to Actin following a 1hr DEX exposure (n=4: 1-
way ANOVA, p=0.0042; post hoc Tukey’s Multiple Comparison Test, *=p<0.05). 
 
 
Figure 15: Triton Fractionation of Cx43 
NPCs prepared from E14.5 mouse embryonic cortices were treated for 1hr with ethanol vehicle 
(Veh) 100nM DEX and/or 1µM RU-486, where indicated. Cells were lysed in 1% Triton X-100 
and PBS and separated into Triton insoluble (membrane) and soluble (cytosolic) fractions via 
high-speed centrifugation. Cell lysates were subjected to SDS-PAGE and Western blot analysis 
for total Cx43 expression. Fig 15 is a representative blot. (n=3). 
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Figure 16: 1hr DEX Exposure Does Not Alter Cx43 Membrane Localization 
Fig 16 displays the mean +SEM of the ratio of Cx43 soluble/insoluble fractions of densitometric 
scans of multiple blots.  The bars represent Cx43 insoluble/Cx43 soluble fractions following 1hr 
DEX exposure.  A 1hr DEX exposure had no effect on the ratio of Cx43 localized to the soluble 
vs. insoluble cell fraction. (n=3). 
3.3 BRIEF GC EXPOSURE LEADS TO RAPID PHOSPHORYLATION OF ERK-1/2 
Cx43 activity is differentially regulated by a variety of kinases. For example, phosphorylation of 
Cx43 at serines 279 and 282 by the mitogen-activated protein kinase (MAPK), extracellular 
signaling kinase-1/2 (ERK-1/2), leads to an inhibition of GJIC (Solan and Lampe 2009). MAPKs 
have been previously implicated in rapid GR and ER non-classical signaling (Qiu et al. 2001; 
Cato et al. 2002; Moriarty et al. 2006). A 1hr DEX exposure of NPCs led to a GR-dependent 
activation of ERK-1/2, as measured by Western blot analysis using a phospho-specific ERK-1/2 
antibody (Fig 17 and 18).  A detailed time-course of ERK-1/2 activation following DEX 
treatment revealed a rapid and biphasic increase in pERK-1/2.  Specifically, pERK-1/2 is 
significantly increased 2min following DEX treatment then decreases to baseline at 15 and 
  49 
30min, but is significantly increased again following a 1hr DEX treatment (Fig 19 and 20).  
Importantly, ERK-1/2 remains activated following an exposure to DEX (i.e. at 1hr), which we 
have shown triggers increased overall Cx43 phosphorylation and reduced GJIC. 
 
 
Figure 17: pERK-1/2 Protein Levels Following 1hr DEX Exposure 
Total protein lysates from NPCs treated for 1hr with 100nM DEX and/or 1µM RU-486 were 
subjected to Western blot analysis to assess phosphorylated-ERK-1/2 (pERK-1/2) and total 
ERK-1/2 (tERK-1/2).  Fig 17 is a representative Western blot. (n=4). 
 
 
 
Figure 18: 1hr DEX Exposure Leads to a Significant Increase in pERK-1/2 Levels 
Fig 18 is a densitometric scan of multiple blots.  The bars represent the ratio of pERK/tERK 
following 1hr DEX exposure. Significant effects of DEX treatment on pERK-1/2 levels are 
observed (n=4; 1-way ANOVA, P=0.0085; post hoc Tukey’s Multiple Comparison Test, 
*=P<0.05). 
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Figure 19: Time Course of pERK-1/2 Protein Levels Following DEX Exposure 
Total protein lysates from NPCs treated for various times between 2min and 1hr with 100nM 
DEX.  Lysates were subjected to Western blot analysis to assess phosphorylated-ERK-1/2 
(pERK-1/2) and total ERK-1/2 (tERK-1/2). Image is a representative Western blot. (n=5). 
 
 
 
Figure 20: DEX Exposure Leads to a Rapid and Biphasic Increase in pERK-1/2 
Levels 
 
Fig 20 represents a densitometric scan from multiple blots of pERK-1/2/ERK-1/2 following 
DEX exposure. Significant effects of DEX treatment on pERK-1/2 levels were observed at 2min 
and 60min of DEX exposure (n=4; 1-way ANOVA, P=0.0050; post hoc Tukey’s Multiple 
Comparison Test, *=P<0.05). 
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3.4 GC EXPOSURE LEADS TO RAPID, SITE SPECIFIC, PHOSPHORYLATION 
OF CX43 
In order to determine if Cx43 phosphorylation at the ERK-1/2 target sites occurs in response to 
GC exposure, Western blot analysis was performed using an antibody directed against Cx43 
phosphorylated at serines 279 and 282 (pCx43s279s282) and using an antibody against Cx43 
phosphorylated at serine 255 (pCx43s255).  As shown in Figures 21 and 22, a 1hr DEX exposure 
of NPCs led to a significant increase in pCx43s279s282.  This increase was not present in NPCs 
treated with DEX and RU-486 (Fig. 21 and 22).  Interestingly, as shown in figures 23 and 24 
DEX exposure did not lead to a significant effect on pCx43s255.    
 
 
Figure 21: pCx43s279s282 Protein Levels Following 1hr DEX Exposure 
Total protein lysates from NPCs treated for 1hr with ethanol vehicle (Veh), 100nM DEX and/or 
1µM RU-486 were subjected to Western blot analysis to assess phosphorylated connexin 43 at 
serine 279 and 282 (pCx43s279s282) and Actin.  A representative Western blot is shown in Fig 
21. (n=4).  
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Figure 22: 1hr DEX Exposure Leads to a Significant Increase in pCx43s279s282 
Levels 
 
Fig 22 represents a densitometric scan from multiple blots of pCx43s279s282 following a 1hr 
DEX exposure. Significant effects of DEX treatment on pCx43s279s282 were observed (n=4; 1-
way ANOVA, P=0.0023; post hoc Tukey’s Multiple Comparison Test, *=P<0.05). 
 
 
Figure 23: pCx43s255 Protein Levels Following 1hr DEX Exposure 
Total protein lysates from NPCs treated for 1hr with ethanol vehicle (Veh), 100nM DEX, and/or 
1µM RU-486 were subjected to Western blot analysis to assess phosphorylated connexin 43 at 
serine 255 (pCx43s255) and Actin.  A representative Western blot is shown in Fig 23. (n=4).  
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Figure 24: 1hr DEX Exposure Does Not Alter pCx43s255 Levels 
Fig 24 represents a densitometric scan from multiple blots of pCx43s255 following a 1hr DEX 
exposure. Significant effects of DEX treatment on pCx43s255 were not observed. (n=4). 
3.5 GC INDUCED CX43 PHOSPHORYLATION AND REDUCTION OF GJIC ARE 
ERK-1/2 DEPENDENT 
In order to determine if GR effects on Cx43 phosphorylation and function are dependent on 
ERK-1/2, Western blot analysis of pCx43s279s282 and FRAP were performed in the presence of 
the MEK-1/2 inhibitor PD98059 (PD).  A 40µM dose of PD inhibits DEX mediated ERK-1/2 
activation (Fig. 25).  As shown in Figures 26 and 27, a 40µM PD co-treatment of NPCs 
prevented the increase in pCx43s279s282 following 1hr DEX exposure. In addition, 40µM PD 
treatment also prevented the DEX-mediated decrease in GJIC (Fig. 28).  Therefore, ERK-1/2 
activation appears necessary for phosphorylation of Cx43 at serine 279/282 and for the DEX-
mediated inhibition of GJIC.  
  54 
 
Figure 25: pERK-1/2 Protein Levels Following 1hr DEX and PD Exposure 
Western blot of total protein lysates from NPCs treated for 1hr with ethanol vehicle (Veh), 
100nM DEX, and/or 40µM PD98059.  Lysates were subject to Western blot analysis to measure 
levels of pERK-1/2 and tERK-1/2. (n=1).  
 
 
 
Figure 26: pCx43s279s282 Protein Levels Following 1hr DEX and PD Exposure 
Total protein lysates from NPCs treated for 1hr with ethanol vehicle (Veh), 100nM DEX, and/or 
40µM PD98059 were subject to Western blot analysis to measure levels of pCx43s279s282 and 
Actin.  Fig. 26 is an image of a representative Western blot. (n=4).  
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Figure 27: PD Co-Tx Inhibits the Increase of pCx43s279s282 Following 1hr DEX 
Exposure 
 
Fig. 27 displays results of the mean + SEM of densitometric scans of multiple Western blots 
from NPC lysates subject to 1hr DEX and/or PD treatment.  The DEX induced increase in PD is 
attenuated by PD co-treatment (n=4; 1-way ANOVA, P=0.0012; post hoc Tukey’s Multiple 
Comparison Test, *=P<0.05). 
 
 
 
Figure 28: PD Co-Tx Inhibits the Decrease in GJIC Induced by 1hr DEX Exposure 
NPCs preloaded with Calcein AM were subjected to ethanol vehicle (Veh) or 100nM DEX +/- 
40µM PD followed by FRAP analysis to measure GJIC. Mean values for t1/2  +SEM of recovery 
are shown in Fig 28. PD co-treatment prevented the DEX mediated reduction in GJIC (n=5 
independent experiments,1-way ANOVA, P=0.0002; post hoc Tukey’s Multiple Comparison 
Test, *= P<0.05). 
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3.6 DENOVO GENE TRANSCRIPTION IS NOT NECESSARY FOR GC EFFECTS 
ON CX43 PHOSPHORYLATION OR GC INHIBITION OF GJIC 
In order to further corroborate the pathway of non-classical GR effects on GJIC, DEX-exposed 
NPCs were subjected to a 1hr pretreatment with 100ng/mL of the transcriptional inhibitor 
Actinomycin D (ActD).  Quantitative RT-PCR (qRT-PCR) indicated that 1hr ActD pretreatment 
effectively inhibited DEX induction of the GC responsive gene glucocorticoid-induced leucine 
zipper (GILZ) (Fig. 29).  Western blot analysis indicates that ActD pretreatment had no effect on 
the induction of pCx43s279s282 following 1hr DEX treatment (Fig. 30 and 31).  Similarly, gap-
FRAP experiments reveal that ActD pretreatment had no effect on inhibition of GJIC following 
1hr DEX exposure (Fig. 32).  These results, along with those from previous studies with DEX-
BSA (Fig. 9) support the notion that a non-classical transcription-independent mechanism 
underlies GC effects on GJIC in NPC cultures. 
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Figure 29: 100ng/mL ActD Pretreatment Prevents DEX Induction of a GR Target 
Gene 
 
NPCs prepared from E14.5 mouse embryonic cortices were pretreated for 1hr with various 
concentrations of the transcriptional inhibitor Actinomycin D (ActD) followed by a 1hr exposure 
to 100nM DEX.  Cells were lysed in Trizol, RNA was extracted, and cDNA was prepared from 
the RNA template.  Expression of the GR target gene glucocorticoid induced leucine zipper 
(GILZ) relative to the house-keeping gene GAPDH was measured by qRT-PCR.   100ng/mL of 
ActD pretreatment was sufficient to prevent DEX induced GILZ expression. (n=1).  
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Figure 30: pCx43s279s282 Protein Levels Following 1hr ActD Pretreatment and 1hr 
DEX Exposure 
 
Western blot of total protein lysates from NPCs  pretreated with 100ng/mL ActD prior to a 1hr 
100nM DEX treatment. Ethanol vehicle (Veh) was used as a control.  Lysates were subject to 
Western blot for pCx43s279s282 and Actin. Fig 30 is a representative blot. (n=4). 
 
 
Figure 31: ActD Pretreatment Does Not Inhibit Cx43 Phosphorylation at s279s282 
Following a 1hr DEX Exposure. 
 
Fig. 31 displays results of the mean + SEM of densitometric scans of multiple Western blots 
from NPC lysates subject to 1hr ActD pretreatment followed by a 1hr DEX exposure.  
Transcriptional inhibition by ActD did not alter DEX induced Cx43 phosphorylation at s279s282 
(n=4; 1-way ANOVA, P=0.0009; post hoc Tukey’s Multiple Comparison Test, *=P<0.05).  
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Figure 32: ActD Pretreatment Does Not Alter the Reduction in GJIC Following a 
1hr DEX Exposure. 
 
NPCs preloaded with Calcein AM were subjected to 100ng/mL ActD pretreatment +/- 100nM 
DEX followed by FRAP analysis to measure GJIC.  Ethanol vehicle (Veh) was used as a control. 
Mean values for t1/2  +SEM of recovery are shown in Fig. 32.  ActD pretreatment had no effect 
on the DEX mediated reduction in GJIC (n=4 independent experiments, 1-way ANOVA, P 
<0.0001; post hoc Tukey’s Multiple Comparison Test, *=P<0.05) 
3.7 GR IS ASSOCIATED WITH CAVEOLIN-1 IN LIPID RAFTS OF NPCS 
Caveolae are specialized membrane invaginations localized to sphingolipid-rich domains called 
lipid rafts (Langlois et al. 2008).  Caveolin-1 (Cav-1) is a major protein component of caveolae 
and has been implicated in membrane GR signaling and in facilitating Cx43 dependent GJIC 
(Langlois et al. 2008; Matthews et al. 2008).  Specifically, Cav-1 has been found to co-
immunoprecipitate with Cx43 and overexpression of Cav-1 has been shown to increase GJIC 
(Matthews et al. 2008). Therefore, two independent biochemical analyses were performed to 
reveal whether GR is associated with Cav-1 in NPCs. Western blot analysis of sucrose gradient 
fractions revealed expression of GR in the Cav-1 enriched membrane fraction (i.e. Fractions 4-6; 
Fig. 33). GR expression in the Cav-1 enriched fraction remains relatively constant following 1hr 
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DEX exposure (Fig. 33).  As an independent assessment of GR/Cav-1 interactions, co-
immunoprecipitation experiments were performed with whole cell-free lysates from NPC 
cultures. As shown by reciprocal co-immunoprecipitation experiments in Figures 34 and 35, GR 
and Cav-1 exist in a complex that is not affected by a 1hr DEX exposure. 
 
 
 
Figure 33: GR is Present in the Cav-1 Enriched Membrane Fraction 
Ethanol vehicle (Veh) or 1hr 100nM DEX (1hr DEX) treated NPC extracts subjected to sucrose 
gradient fractionation to enrich for Cav-1 membrane fractions (i.e. fractions 4-6) were analyzed 
for GR and Cav-1 expression using Western blots.  One representative blot is shown in Fig 33. 
(n=2). 
 
 
 
Figure 34: Cav-1 IP; GR Associates with Cav-1 in a DEX Independent Manner 
Triton-soluble extracts were subjected to a co-immunoprecipitation assay with subsequent 
Western blot to reveal an association between GR and Cav-1.  Extracts were subject to 1hr 
ethanol vehicle (IP-Veh) or 100nM DEX (IP-DEX) exposure.  A non-immune IgG was used as a 
control co-immunoprecipitation. A representative blot is shown in Fig 34. (n=3). 
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Figure 35: GR IP; Cav-1 Associates with GR in a DEX Independent Manner 
Triton-soluble extracts were subjected to a co-immunoprecipitation assay with subsequent 
Western blot to reveal an association between GR and Cav-1 Extracts were subject to 1hr ethanol 
vehicle (IP-Veh) or 100nM DEX (IP-DEX) exposure.  A non-immune IgG was used as a control 
co-immunoprecipation. A representative blot is shown in Fig 35. (n=3). 
3.8 C-SRC INHIBITION PREVENTS GC ACTIVATION OF ERK-1/2 
GR and the non-receptor tyrosine kinase c-src have been previously reported to localize to Cav-1 
enriched membrane fractions. Furthermore, c-src was found to be a critical downstream signaling 
protein in a GR non-classical signaling mechanism (Matthews et al. 2008).  In light of our 
findings revealing a GR/Cav-1 interaction (Fig 33-35), we examined the role of c-src on GC-
induced ERK-1/2 activation.  A 30min pretreatment of NPCs with 10µM of the src family 
inhibitor PP2 followed by a 1hr DEX exposure prevented the DEX-mediated increase in pERK-
1/2 (Fig 36 and 37) suggesting that c-src activation is coupled to GR-dependent ERK-1/2 
activation and Cx43 phosphorylation. 
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Figure 36: pERK-1/2 Protein Levels in PP2 Pretreated NPCs Subject to 1hr DEX 
Exposure 
 
Total protein lysates from NPCs pretreated with 10µM PP2 for 30min followed by a 1hr 
exposure to 100nM DEX were subjected to Western blot analysis to measure pERK-1/2 levels.  
Fig 36 represents a representative blot. (n=6). 
 
 
 
Figure 37: PP2 Pretreatment Inhibits ERK-1/2 Activation Following a 1hr DEX 
Exposure. 
 
Fig 37 displays the results of the mean + SEM of densitometric scans of multiple Western blots 
from NPC lysates subject to PP2 pretreatment followed by a 1hr DEX exposure. Ethanol vehicle 
(Veh) was used as a control.  Significant effects of DEX were revealed in results of the mean 
+SEM ratio of pERK/tERK from densitometric scans of multiple blots (n=6; 1-way ANOVA, P 
=0.0001; post hoc Bonferroni’s Multiple Comparison Test, *=P<0.05). 
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3.9 TRANSIENT GC EXPOSURE IS SUFFICIENT TO REDUCE S PHASE 
PROGRESSION IN NPCS AND ENHANCE CELL CYCLE EXIT 
GC inhibition of NPC proliferation observed in-vitro could underlie the detrimental effects of 
embryonic exposure to these hormones that has been observed in animal and clinical studies 
(Yeh et al. 2004; Yu et al.). While transcriptional targets of GR that influence cell cycle 
progression in NPCs have been identified, the contribution of non-classical GR signaling to NPC 
proliferation has not been addressed (Rogatsky et al. 1997; Ayroldi et al. 2007).  Both classical 
and non-classical actions of estrogen receptor (ER) regulate breast cancer cell proliferation 
providing precedence for multi-level action of steroid receptors in cell cycle control (Razandi et 
al. 2004; Levin 2005).  
A prolonged (i.e. 24hr) DEX treatment reduced NPC proliferation in these cultures (Fig 
38-39), as observed in NPCs obtained from other brain regions and ages (Sundberg et al. 2006; 
Yu et al.). NPC proliferation in neurosphere cultures was not altered upon a simultaneous 24hr 
treatment with RU-486 and DEX, demonstrating the GR dependence of the anti-proliferative GC 
effects. Figure 38 and 39 display the two independent assays used to assess NPC proliferation in 
neurosphere cultures. A 1hr BrdU pulse immediately preceding cell harvest was used to identify 
cells progressing through S phase. NPCs positive for BrdU staining were revealed by indirect 
immunofluorescence (IIF) with an anti-BrdU antibody. IIF was also used to detect NPCs positive 
for Ki67, which is expressed in cells actively progressing through the cell cycle (i.e. G1, S, 
G2/M). Cells that have exited the cell cycle (i.e. G0) no longer express Ki67. 
In order to limit the duration of GR activity, RU-486 was added to neurosphere cultures 
following a 1hr pre-exposure to DEX (preDEX+RU). NPC proliferation was then assessed 23hrs 
later using a 1hr BrdU pulse and Ki67 staining as described above. As shown in Figures 38 and 
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39, a 1hr DEX “pulse” was sufficient to generate an antiproliferative effect on NPCs as assessed 
by both BrdU and Ki67 staining. The reduction in BrdU incorporation and Ki67 staining in 
NPCs exposed chronically or transiently to DEX suggests that GCs are both limiting the entry of 
NPCs into S phase and enhancing cell cycle exit. 
 
Figure 38: A 1hr DEX Exposure Reduces BrdU+ NPCs 24hrs Following Treatment 
NPCs were subjected to the following 24 hr treatments; ethanol vehicle (Veh), 100nM DEX (+/- 
1µM RU-486), RU-486 alone, or a 1hr DEX pretreatment followed by a 23 Hr RU-486 exposure 
(1hr PreDEX +RU).  NPCs were treated with a 10µM BrdU pulse during the final hour of 
hormone exposure and then processed for immunostaining to detect BrdU incorporation and 
Ki67 expression. Mean values for BrdU+/Ki67+ cells +SEM in Fig 38 panel A show a 
significant reduction in NPCs actively in S-phase of the cell cycle (n=3; 4 random fields per 
image; 1-way ANOVA, P =0.0024; post hoc Tukey’s Multiple Comparison Test, *=P<0.05).  
Panel B is a representative image. 
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Figure 39: A 1hr DEX Exposure Reduces Ki67+ NPCs 24hrs Following Treatment 
NPCs were subjected to the following 24 hr treatments; ethanol vehicle (Veh), 100nM DEX (+/- 
1µM RU-486), RU-486 alone, or a 1hr DEX pretreatment followed by a 23 Hr RU-486 exposure 
(1hr PreDEX +RU).  NPCs were treated with a 10µM BrdU pulse during the final hour of 
hormone exposure and then processed for immunostaining to detect BrdU incorporation and 
Ki67 expression.  Analysis of Ki67 immunostained cells alone (Fig 39) indicated a significant 
reduction in NPCs actively engaged in any phase of the cell cycle (i.e. G1-S-G2/M) (n=4; 4 
random fields per image; 1-way ANOVA, P <0.0001; post hoc Tukey’s Multiple Comparison 
Test, *= P<0.05). 
 
3.10 TRANSIENT INHIBITION OF GJIC IS SUFFICIENT TO REDUCE S PHASE 
PROGRESSION IN NPCS BUT DOES NOT TRIGGER CELL CYCLE EXIT 
While the 1hr DEX “pulse” used above may not necessarily limit GR to non-classical effects, 
this duration of GC exposure does initiate a non-classical and transcription-independent 
signaling pathway in NPCs.  This culminates in reduced GJIC between connected cells (Fig 8).  
In order to examine whether a transient inhibition of GJIC (e.g. brought about by non-classical 
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GR signaling) could affect NPC proliferation, NPC proliferation assays were performed 
following exposure of neurosphere cultures to the reversible GJIC inhibitor 1-heptanol (Kimura 
et al. 1995).  Treatment of neurosphere cultures with 3mM 1-heptanol led to a loss in GJIC in 
NPCs that was sustained for 1hr, but could be rapidly reversed following removal of 1-heptanol 
(Fig 40).  NPC proliferation was then examined by exposing neurosphere cultures to 3mM 1-
heptanol for only 1hr. Specifically, cultures were extensively washed in fresh media following 
this exposure and proliferation assessed 23hrs later by a 1hr BrdU pulse and subsequent IIF to 
detect BrdU and Ki67 positive cells. As shown in Figure 41, a 1hr 1-heptanol exposure led to a 
significant reduction in BrdU positive NPCs, but surprisingly, did not have any effect on the 
number of Ki67 positive cells (Fig 42). Therefore, while either transient GR activation or GJIC 
inhibition is sufficient to limit NPC entry into S phase, cell cycle exit most likely requires 
additional actions of GR that extend beyond its non-classical effects limiting GJIC. 
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Figure 40: Heptanol Exposure Transiently Reduces GJIC in NPCs 
NPCs preloaded with Calcein AM were subjected to the following treatments: Ethanol vehicle 
(Veh), 2 min 1-heptanol (Hept), 1hr Hept, and 1hr Hept followed by a wash into heptanol free 
media (Hept Wash). 3mM Hept was used in all treatments.  Mean values for t1/2 +SEM of 
recovery obtained by fitting a decayed exponential to individual fluorescence recovery curves 
show reversible inhibition of GJIC by Hept (n=4, 1-way ANOVA, P <0.0001; post hoc Tukey’s 
Multiple Comparison Test, *=P<0.05). 
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Figure 41: 1hr Hept Exposure Reduces BrdU+ NPCs 24hrs Following Treatment 
 
The proliferation assay in Fig 41 Panel A was performed as described above (see Fig 39) 
following a 1hr 3mM heptanol exposure followed by washout.  The results reveal a significant 
effect of a limited (i.e. 1 hr) heptanol exposure on NPCs actively progressing through S-phase of 
the cell cycle measured 23 Hrs following heptanol removal and wash (1hr Hept/23hrWash). (Fig 
41 panel A: mean number +SEM of BrdU+/Ki67+ cells, n=4; 4 random fields per image; 1-way 
ANOVA, P <0.0001; post hoc Tukey’s Multiple Comparison Test, *=P<0.05).  Fig 41 Panel B is 
a representative image. 
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Figure 42: 1hr Hept Exposure Has No Effect on Ki67+ NPCs 24hrs Following 
Treatment 
 
The proliferation assay in Fig 42 was performed as described above (see Fig 39) following a 1hr 
heptanol exposure followed by washout.  Analysis of mean +SEM of Ki67 only labeled cells 
(Fig 42) reveals no significant effect of the limited heptanol exposure on NPCs exiting the cell 
cycle. (n=4). 
3.11 CAV-1 IS NECESSARY FOR RAPID GC MEDIATED ERK-1/2 
PHOSPHORYLATION, CX43 PHOSPORYLATION, AND REDUCTION OF GJIC 
In order to definitively assess the role of cav-1 in the signaling cascade that leads to GC 
mediated Cx43 phosphorylation and a reduction in GJIC, experiments were performed on NPCs 
derived from Cav-1 knockout (Cav-1 KO) animals.   Exposure of Cav-1 KO NPCs to 1hr of 
DEX did not lead to a significant change in pERK-1/2 levels as measured by Western blot (Fig 
43 and Fig 44).  A 1hr DEX exposure of Cav-1 KO NPCs also did not have any significant 
effects on pCx43s279s282 (Fig 45 and Fig 46).  In order to determine the functional effect of 
Cav-1 KO on GJIC, FRAP experiments were performed as described previously.  No significant 
effects on GJIC were observed from a 1hr DEX exposure of Cav-1 KO NPCs (Fig 47).  In 
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combination, these results indicate that cav-1 is essential for rapid GC mediated signaling that 
results in ERK-1/2 mediated Cx43 phosphorylation at s279/s282 and subsequent reductions in 
NPC GJIC.   
 
Figure 43: pERK-1/2 Levels in Cav-1 KO NPCs Following 1hr DEX Exposure 
Total protein lysates from Cav-1 KO NPCs treated for 1hr with ethanol vehicle, 100nM DEX, 
and/or 1µM RU-486 were subjected to Western blot analysis to assess phosphorylated-ERK-1/2 
(pERK-1/2) and total ERK-1/2 (tERK-1/2).  Fig 43 panel A is a representative Western blot. 
(n=3). Fig 43 Panel B displays total lysates from Cav-1 KO and WT NPCs subject to Western 
blot analysis to assess Cav-1 and Actin. (n=1).  
 
 
Figure 44: 1hr DEX Exposure of Cav-1 KO NPCs Has No Significant Effect on 
ERK-1/2 Activity 
 
Fig 44 is a densitometric scan of multiple blots.  The bars represent the ratio of pERK/tERK 
following 1hr DEX exposure.  No significant effects of DEX treatment on pERK-1/2 levels are 
observed.  Error bars are +SEM.  (n=3). 
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Figure 45: pCx43s270s282 Levels in Cav-1 KO NPCs Following 1hr DEX Exposure 
 
Total protein lysates from Cav-1 KO NPCs treated for 1hr with ethanol vehicle, 100nM DEX, 
and/or 1µM RU-486 were subjected to Western blot analysis to assess phosphorylated-Cx43 
(pCx43s279s282) and Actin.  Fig 45 is a representative Western blot. (n=3). 
 
 
Figure 46: 1hr DEX Exposure of Cav-1 KO NPCs Has No Significant Effect on 
pCx43s279s282 
 
Fig 46 is a densitometric scan of multiple blots.  The bars represent the ratio of 
pCx43s279s282/Actin following 1hr DEX exposure.  No significant effects of DEX treatment on 
pCx43s279s282 levels are observed.  Error bars are +SEM.  (n=3). 
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Figure 47: 1hr DEX Exposure of Cav-1 KO NPCs Does Not Alter GJIC 
 
Cav-1 KO and WT NPCs preloaded with Calcein AM were subjected to the following 
treatments: Ethanol vehicle (Veh) or 100nM DEX (DEX).  Mean values for t1/2 +SEM of 
recovery were obtained by fitting a decayed exponential to individual fluorescence recovery 
curves.  No effects of DEX exposure were observed on GJIC in Cav-1 KO NPCs (n=4).   
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4.0  DISCUSSION 
4.1 SUMMARY OF RESULTS 
In this report, we identify a non-classical and non-genomic GR signaling pathway that impacts 
NPC proliferation in-vitro through inhibitory effects on GJIC. Phosphorylation of specific 
connexin proteins has been shown to regulate GJIC in other systems.  In agreement, we provide 
evidence for rapid activation of ERK-1/2 by GCs that triggers site specific phosphorylation of 
Cx43, a major component of NPC gap junctions.  This phosphorylation event, in turn, leads to 
reduced GJIC.  Interestingly, GCs do not appear to influence Cx43 (or Cx26) protein expression 
or subcellular trafficking in murine NPCs.  Rapid GR-dependent activation of ERK-1/2 requires 
a c-src family member and may be initiated by a signaling complex assembled at the plasma 
membrane through GR interactions in lipid rafts containing caveolin-1. Our studies corroborate 
the role for caveolin-1 in mediating the anti-proliferative effects of GCs that was established 
previously in MEFs from caveolin-1 knockout animals (Jasmin et al. 2009).  In addition, we 
identify a novel downstream target of this signaling, GJIC, in a progenitor cell population that 
could utilize GJIC and/or connexins to maintain synchrony of cell division. 
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Figure 48: Activation of non-classical and classical pathways by GCs alter NPC 
proliferation 
 
Hormone (GC) treatment leads to rapid signaling by membrane GR associated with cav-1.  
Rapid activation of c-src leads to ERK-1/2 activation, phosphorylation of Cx43, and reduction of 
GJIC.  This non-classical signaling reduces s-phase entry.  In addition, DEX activates classical, 
transcription-dependent processes that also reduce NPC proliferation. 
 
4.2 NON-CLASSICAL MEMBRANE GR SIGNALING 
Both sucrose gradient fractionation experiments as well as co-IP studies reveal an association 
between cav-1 and GR and localization of GR to cav-1 enriched portions of the plasma 
membrane.  We also observed that a membrane impermeable DEX-BSA elicits a reduction in 
GJIC, suggesting that a membrane GC receptor underlies the rapid effects that we have 
documented.  Finally, we demonstrated that ERK-1/2 activation, Cx43s279s282 
phosphorylation, and a reduction in GJIC were absent in 1hr DEX exposed Cav-1 KO NPCs.  
These observations raise a few interesting questions regarding the nature of the GR underlying 
these effects.  First, how does the receptor reach the membrane? Second what is the precise role 
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of cav-1 in facilitating non-classical GR signaling?  Third, is the membrane GR similar to the 
nuclear GR (GRα)?  
4.2.1 Palmitoylation of Membrane Hormone Receptors 
Both the presence of GR on the plasma membrane as well as its association with cav-1 bears 
many similarities to the other major classes of steroid hormone receptors such as ER, PR, and 
AR.  The mechanisms of plasma membrane association and signaling that have previously been 
identified for these receptors may therefore provide important insights into plasma membrane 
initiated signaling by GR.  For example, a conserved nine amino acid sequence containing a 
cysteine residue in the ligand binding domain (E-domain) of ERα, ERβ, PR, and AR seems 
essential for their plasma membrane localization (See Fig 4, Introduction). This particular 
cysteine residue is subject to palmitoylation, and this form of lipidation seems to be a necessary 
prerequisite for plasma membrane localization.  In addition, mutation of hydrophobic amino 
acids at +5/6 position relative to the cysteine, phenylalanine or tyrosine residues at the -2 
position also significantly reduced membrane localization of these steroid receptors (Pedram et 
al. 2007).  Cav-1 has been hypothesized to be essential for localization of receptor to cav-1 
enriched rafts within the plasma membrane and for transport of palmitoylated receptor to the 
membrane (Levin 2009). 
Apart from the presence of the palmitoyl group, the membrane version of these receptors 
is identical to the nuclear versions (Pedram et al. 2007). For example, transfection of ER null 
cells that lack both nuclear and membrane ER with ERα or ERβ leads to both membrane and 
nuclear localization, and membrane ER isolated from breast cancer cells was identical to ERα by 
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mass spectroscopy (Hammes and Levin 2007).  Interestingly, GR also contains a very similar 
nine amino acid sequence in its E-domain, including a cysteine at the 3 position (Groeneweg et 
al. 2011).   In responses to the questions posed earlier, this suggests the possibility that the 
membrane GR is also a similarly palmitoylated version of the nuclear GR, and that like AR, PR, 
and ER, depends on its association with cav-1 to localize and function as a membrane receptor.  
4.2.2 MR a Perfect Partner for GR? 
Interestingly, one member of the nuclear steroid hormone superfamily that lacks the 
conserved nine amino acid sequence in its E-domain, including the cysteine residue, is the other 
GC receptor, the MR (Groeneweg et al. 2011).  MR has been shown to be important in rapid 
non-classical signaling and has a similar motif in its N-terminal domain to the ERα sequence that 
was shown to be important for ER interaction with cav-1 (Freeman et al. 2005; Groeneweg et al. 
2011).  Taken together, these findings suggest that rapid MR signaling may be localized to lipid 
rafts and involve cav-1, but that localization of the MR to the cell membrane utilizes a distinct 
mechanism than GR.  This difference may be an important factor in determining the differential 
responses of GR and MR to GC in non-classical signaling.  For example, palmitoylation of the 
GR may lead to GR localization in a distinct compartment within cav-1 containing lipid rafts.  
This may, in turn, influence the signaling cascades activated by GR vs. MR in response to the 
same ligand (GC).   
Furthermore, the potential requirement of palmitoylation for GR but not MR membrane 
localization necessarily means that a unique subset of cell machinery is required to integrate GR 
versus MR at the cell membrane.  This difference may be highly influenced by the physiological 
state of the cell (i.e. type of stimulation, extracellular milieu, etc.) necessary for receptor 
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membrane localization.  The timing, the duration, and the speed at which the receptor reaches the 
membrane could also be affected by this difference.  These factors may partly explain reports 
documenting differences in GC mediated non-classical signaling arising from MR vs. GR 
(Groeneweg et al. 2011).  For example, both GR and MR are expressed in the hippocampus and 
non-classical MR signaling was found to increase mEPSC frequency.  GR knockout did not alter 
this effect, confirming that this was an MR dependent phenotype.  In contrast, non-classical GR 
action was shown to underlie a corticosterone-dependent increase in hippocampal spine density.  
In the basolateral amygdala, non-classical MR increased mEPSC frequency following a single 
administration of GC.  A second GC exposure decreased mEPSCs, but this effect was mediated 
through GR, and also occurred through a rapid non-classical mechanism (Groeneweg et al. 
2011).  As a final point, the diversity of GR vs. MR responses to the identical ligand is not 
without precedence and is also the case for genomic signaling from these receptors.  Despite 
sharing almost identical DNA binding domains, GR and MR only have 30% overlap in terms of 
the genes they activate (Groeneweg et al. 2011).  It is therefore not entirely surprising that 
similar principles may also hold for non-classical signaling from these receptors. 
4.2.3 The Association of GR and Cav-1 During Plasma Membrane Signaling 
We also observed that the membrane GR and cav-1 association was not altered by DEX 
treatment.  This is in contrast to the finding that cav-1 displacement occurs following membrane 
ER activation in MCF-7 cells or following ligand stimulation of membrane tyrosine kinase 
growth factor receptors.  This displacement appears to be necessary for subsequent membrane 
signaling (Razandi et al. 2002; Hammes and Levin 2007).  While in many instances a decreased 
association between cav-1 and a membrane signaling receptor is observed during activation of a 
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signaling cascade, this is not always the case.  For example, a stronger interaction between ER 
and cav-1 was observed in vascular smooth muscle (VSM) cells following E2 stimulation and 
activation of membrane ER signaling.  This was, however, followed by an ER-mediated 
inhibition of ERK-1/2 signaling (Razandi et al. 2002).  We did not detect a change in the 
observed association of cav-1 and GR by co-IP in response to hormone stimulation.  Our results 
therefore suggest that hormone effects on NPC GJIC and proliferation may be mediated by 
conformational changes in GR that alter receptor interactions with components of the MAPK 
pathway, including, for example, c-src family members.   
This is in part similar to the result observed following E2 stimulation of membrane ER in 
VSM cells.  However, we documented an increase in ERK-1/2 activation.  Interestingly, 
inhibition of ERK-1/2 in VSM cells following membrane ER activation was associated with a 
reduction in VSM cell proliferation (Razandi et al. 2002).  The GC-mediated increase in ERK-
1/2 activity that we observed in NPCs is associated with a similar physiological outcome; namely 
a decrease in the rate of NPC proliferation.   
Cell-type specific differences in targets may therefore underlie the contrasting effects on 
ERK-1/2 resulting from membrane steroid hormone signaling in VSM cells vs. NPCs.  In the 
case of VSM cells, ERK-1/2 inhibition leads to a reduction in activation of cell cycle target 
genes such as cyclin D1, thus inhibiting proliferation (Razandi et al. 2002). In NPCs, Cx43 is a 
downstream target of GC-activated ERK-1/2 with site-specific phosphorylation associated with 
reduced GJIC, which, in turn, contributes to decreased proliferation. 
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4.3 INTEGRATION OF CLASSICAL AND NON-CLASSICAL GR SIGNALING  
The rapid activation of both non-classical and classical signaling pathways by GR may 
account for the decrease in NPC proliferation (i.e. S phase progression) and increased cell cycle 
exit (i.e. as assessed by Ki67 immunoreactivity) brought about by a transient (1hr) DEX 
exposure.  A transient inhibition of GJIC by 1-heptanol in the absence of GR activation also 
reduced S phase progression of NPCs, but did not affect cell cycle exit.  Non-classical and 
transcription-independent GC effects mediated by a reduction in GJIC may lead to a decrease in 
the rate of cell cycling in S-phase, whereas transcription-dependent effects, including some that 
have been previously characterized, may force NPCs to exit the cell cycle entirely (Sundberg et 
al. 2006).  In the following sections, I will explore the possible interaction between non-classical 
and classical effects on NPC proliferation in greater detail. 
 
4.3.1 Ca2+ Waves and NPC Proliferation 
In light of our observation of GJIC inhibition, it is interesting to speculate whether the decreased 
rate of S-phase progression that we have observed in NPCs results from a loss of Ca2+ wave 
propagation.  The propagation of spontaneous Ca2+ waves through gap junction hemichannels 
has been proposed to be an essential component of neuronal proliferation in the developing 
cortex (Weissman et al. 2004).  In particular, Weissman et al. demonstrated that spontaneous 
Ca2+ waves in radial glial cells in the rat embryonic ventricular zone (VZ) are mediated by gap 
junction hemi-channels.  Inhibition of gap junction communication with cbx diminished these 
waves, which, in turn, reduced VZ cell proliferation (Weissman et al. 2004).  In addition, there 
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are numerous contexts in which Ca2+ has been recognized to regulate cell proliferation (Berridge 
et al. 2000).  The primary role of Ca2+ in this setting is in activating Ca2+ responsive transcription 
factors, such as NFAT, that influence cell proliferation.  These findings in conjunction with our 
observations of a loss in GJIC, and a decreased rate of S-phase progression, raise a few 
interesting possibilities. 
For example, GC-mediated reduction of GJIC may inhibit or alter spontaneous Ca2+ 
waves in NPCs akin to the waves that Weissman and colleagues observed in the embryonic rat 
VZ.  The importance of Ca2+ release in NPC proliferation was also shown by Lin et al., who 
demonstrated that Ca2+ release was dependent on ATP activation of P2Y1 surface receptors on 
neurospheres (Lin et al. 2007).  Interestingly, ATP was emitted in spontaneous bursts from the 
proliferating NPCs, and this release was decreased in serum-exposed NPCs that were beginning 
to differentiate.  In addition, loss of the calcium wave, inhibition of the upstream P2Y1 receptor, 
or inhibition of ATP release were each found to diminish cell proliferation, demonstrating an 
intimate link between these players and cell cycle progression (Weissman et al. 2004; Lin et al. 
2007).   
However, Lin et al., 2007 did not address the mechanism whereby ATP exits the NPCs 
prior to binding P2Y1 receptors.  Taken in combination with our results and the observation that 
Ca2+ waves themselves may be dependent on gap junction channels, this suggests a potentially 
central role for gap junctions in regulation of NPC proliferation.  Specifically, gap junction 
channels and hemi-channels may facilitate the release of ATP into the extracellular space, which 
binds P2Y1 receptors and leads to the release of intracellular Ca2+.  The propagation of the Ca2+ 
wave itself is then dependent on GJIC between adjacent cells.  Other small molecules such as IP3 
may also rely on GJIC to travel between adjacent cells.  Changes in gap junction communication 
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therefore may directly affect cell proliferation by altering the passage of multiple metabolites.  
Importantly, this suggests a critical role for gap junctions in facilitating synchronous activity 
between proliferating cells. 
 
Figure 49: Gap Junctions Facilitate The Movement of Spontaneous ATP and Ca+ 
Waves Needed for Proliferation 
 
Open gap junctions may allow passage of ATP, which binds to and activates P2Y1 receptors 
leading to IP3 mediated Ca2+ release from the endoplasmic reticulum (ER).  The Ca2+ itself and 
the IP3 could travel between cells in a gap junction-dependent manner and may facilitate cell 
proliferation. 
 
The observation that Ca2+ is an important regulator of proliferation, and the findings by 
Weissman et al., (2004) suggesting that the disruption of Ca2+ waves diminishes NPC 
proliferation, suggests that targets of this ion are particularly important in regulating the cell 
cycle in neural progenitors (Weissman et al. 2004).  In addition, effects on Ca2+ may explain the 
difference in effects on NPC proliferation that we have observed between 1hr GC exposure and 
1hr inhibition of GJIC alone with heptanol treatment.  In particular, disruption of GJIC alone 
may interrupt Ca2+ induced targets of proliferation and potentially decrease the rate of NPC S-
phase entry.   
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However, GC exposure not only affects Ca2+ targets via gap junction effects, but may 
additionally force the cells out of the cell cycle by activating anti-proliferative GR target genes. 
The alterations in Ca2+ signaling arising from a reduction in GJIC may affect Ca2+ dependent 
transcription factors such as Nuclear Factor of Activated T-cells (NFAT) and cAMP Response 
Binding Element (CREB) (Berridge et al. 2000). 
4.3.2 NFAT- A Potential Target of Disrupted GJIC and Ca2+ 
NFAT refers to a class of multiprotein complexes that act as transcription factors 
(Berridge et al. 2000).  A number of NFAT isoforms require activation via a Ca2+-calmodulin-
calcineurin pathway for nuclear import and trans-activation of target genes (Karpurapu et al. 
2009).  In the presence of an elevated concentration of Ca2+, the calmodulin-calcineurin complex 
becomes activated and dephosphorylates NFAT, leading to its nuclear translocation and 
transcriptional regulation of target genes (Berridge et al. 2000).   
Cyclin D1 has been shown to be an NFAT target gene that has particular relevance to cell 
proliferation.  Studies of proliferation in human aortic smooth muscle cells revealed that cyclin 
D1 has NFAT binding elements in its promoter region.  Activation of the upstream calmodulin 
pathway has no effect on cell proliferation or cyclin D1 expression when NFAT is knocked 
down (Karpurapu et al. 2009).   
The NFAT target gene, cyclin D1, inactivates the retinoblastoma (Rb) protein by 
phosphorylation and promotes the G1-S transition in the cell cycle (Fu et al. 2004).  
Consequently, over-expression of cyclin D1 is associated with a number of human cancers 
including subsets of colon cancer, breast cancer, melanoma, and prostate cancer (Fu et al. 2004).  
It is therefore conceivable that a reduction in GJIC, such as we have observed in NPCs, could 
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interrupt Ca2+ signaling and reduce the rate of S-phase entry by reducing the levels of NFAT 
transcribed cyclin D1.   
In addition, a reduction in cyclin D1 (although purportedly by a ubiquitin-mediated 
pathway) has been shown to play a role in GC-mediated reductions in NPC proliferation, thus 
specifically demonstrating the importance of cyclin D1 in NPC proliferation (Sundberg et al. 
2006).  Furthermore, GJIC has been posited to play a critical role in NFAT-dependent embryonic 
heart valve development.  In NFAT-deficient mice, the outflow valves and the septal structures 
of the heart fail to form.  A remarkably similar phenotype is observed in Cx45 KO animals, and 
cell-imaging studies revealed that NFAT is restricted to the cytoplasm in the Cx45 KO animals.  
Even though a direct link between Cx45-mediated GJIC and NFAT activity or the downstream 
targets of NFAT was not established, the observed effects indicated that the proper development 
and proliferation of these heart valve cells may depend on Cx45 GJIC dependent NFAT 
activation  (Crabtree and Olson 2002).   
It is also known that NFAT is expressed in the developing brain, and disruption of NFAT 
signaling leads to deficits in neuronal development (Nguyen and Di Giovanni 2008).  One 
example involves the Down’s syndrome critical region 1 (DSCR1) protein.  DSCR1 is over-
expressed in fetuses with Down’s syndrome, and leads to inhibition of calcineurin and a 
reduction of NFAT activity, which has been purported to account for some of the 
neurodevelopmental abnormalities Down’s (Ooi and Wood 2008). Taken together, these findings 
suggest the possibility that a GC induced loss in GJIC may lead to decreased S-phase 
progression in NPCs via a Ca+ - NFAT- cyclin D1 dependent process. 
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4.3.3 CREB- A Second Potential Target of Disrupted GJIC and Ca2+ 
CREB is another major target of Ca2+ that has been shown to have important roles in regulating 
cell proliferation (Berridge et al. 2000).  CREB is a nuclear localized transcription factor that is 
activated following phosphorylation at ser133 by a number of kinases including the Ca2+ 
activated Ca2+/calmodulin-dependent protein kinases II and IV (CAMKII and CAMKIV) 
(Berridge et al. 2000).  In order to trans-activate target genes, phosphorylated CREB also needs 
to bind to its Ca2+ activated co-activator, CREB-binding protein (CBP) (Hardingham et al. 1998).  
The CBP-CREB complex has been shown to bind to a CREB response element on the cyclin D1 
promoter (D'Amico et al. 2000; Catalano et al. 2009).  In addition, CREB is expressed in the 
developing brain and is known to be important for the survival and proliferation of NPCs 
(Dworkin et al. 2007; Dworkin et al. 2009).  Ca2+-mediated CREB activation may therefore 
partly drive NPC proliferation through cyclin D1 expression.  The loss or alteration of Ca2+ 
following a reduction in GJIC may reduce the number of cells in S-phase through a CREB-
mediated process.  The alteration of NPC proliferation via effects on Ca2+ target genes such as 
CREB or NFAT may be reversible if GJIC returns to control levels and Ca2+ signaling returns to 
baseline.  In addition, the effects of Ca2+ target genes on cell cycle progression of NPCs most 
likely only represent one pathway of GR regulation of NPC proliferation. 
4.4 GR TARGETS IN NPC PROLIFERATION 
A reduction in GJIC by heptanol exposure for 1hr leads to a reduction in the number of 
NPCs in S-phase of the cell cycle.  In contrast, a 1hr GC exposure, limited by subsequent RU-
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486 treatment, forces NPCs out of the cell cycle entirely.  This important difference suggests that 
GC exposure modulates NPC proliferation through a reduction of GJIC as well as through other 
means.  Therefore, while GC-mediated loss of GJIC may affect NPC proliferation via Ca2+ 
effects as hypothesized above, GCs may also have additional, GR transcriptional target mediated 
effects on NPC proliferation.  One potential set of candidate genes for GR effects on 
proliferation are the established regulators of the cell cycle.  GR may up-regulate the expression 
of factors that cause cell cycle arrest or repress certain factors that promote cell cycling.  In 
particular, GR has been shown to activate the cyclin-dependent kinase inhibitors (CDIs) p27 and 
p21 and GR has also been shown to repress the expression of the cyclin-dependent kinases 
(CDKs) CDK4 and CDK6 (Rogatsky et al. 1997). 
4.4.1 CDKs and CDIs 
CDKs associate with cyclins at particular points in the cell cycle and CDK-cyclin 
complexes phosphorylate and activate proteins that promote cell cycle progression.  CDIs bind to 
the CDK-cyclin complexes and inhibit their kinase activity, thus inhibiting cell cycle progression 
(Rogatsky et al. 1997).  DEX-activated GR in the SAOS2 human osteosarcoma cell line 
upregulates the expression of both p27 and p21 and causes a decrease in proliferation (Rogatsky 
et al. 1997).  The p21 promoter lacks a consensus GRE, but is induced rapidly (mRNA peak 
within 2hrs of GC hormone treatment) even in the presence of translational inhibition with 
cycloheximide treatment.  The promoter does however contain a number of half-GRE-like 
sequences. In addition, a GR dimerization mutant (i.e. a GR that is unable to form the 
homodimers that are typically needed for GR mediated transcription) was able to activate p21 
induction (Rogatsky et al. 1999).  Taken together, these results indicate that ligand-activated GR 
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directly up-regulates p21 expression in an atypical manner in SAOS2 cells.  Specifically, the 
rapid induction of p21 mRNA despite the presence of only a half-GRE sequence suggests that 
GR monomers interact with co-activator proteins to directly up-regulate p21.   
Increased expression of p27 took 24hrs to peak at the mRNA level and did not occur in 
the presence of the GR dimerization mutant.  This increased mRNA expression was sensitive to 
cycloheximide treatment.  These results suggest that GR activates p27 transcription indirectly 
(Rogatsky et al. 1999).   
In contrast, DEX-activated GR had no effect on p27 or p21 in the U2OS human 
osteosarcoma cell line, but did repress CDK4, CDK8, and cyclin D3 activity, which also led to a 
reduction in cell proliferation (Rogatsky et al. 1997).  The precise mechanism whereby GR 
repressed CDK and cyclin activity was not established.  However, the deletion of the N-terminal 
transcriptional activation domain had no effect on ligand-induced GR repression, but deletion of 
the GR zinc finger domain that is critical for certain GR-nonreceptor protein interactions did 
abrogate the repression activity.  Thus, an interaction between ligand bound GR and an 
unidentified transcriptional repressor(s) was likely responsible for the effects observed in U2OS 
cells (Rogatsky et al. 1997).   These examples suggest that GR reduces cell proliferation by 
multiple mechanisms and in a cell type specific manner.  GC-mediated inhibition of NPC 
proliferation may also partly be a result of activation of CDIs or repression of CDKs.  
Importantly, our data suggest that even a 1hr exposure to DEX is sufficient to induce the 
transcription of GR target genes (see GILZ in results) making GR transcriptional effects on 
proliferation a plausible outcome even after a GC exposure limited to 1hr.  
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Figure 50: GR May Alter NPC Proliferation by Non-Classical and Classical 
Mechanisms 
 
Rapid, non-classical GR signaling inhibits GJIC and may disrupt Ca2+ waves.  This may alter the 
activity of Ca2+-dependent transcription factors such as CREB that act on cell cycle proteins such 
as cyclin D1. These effects may be reversible as GJIC returns to pretreatment levels over time.  
A 1hr DEX exposure may also activate classical GR signaling that up-regulates CDIs such as 
p21. The combination of classical and non-classical signaling may have a more lasting impact on 
cell proliferation than inhibition of GJIC alone. 
 
4.4.2 GILZ, a Direct GR Target 
GR is also known to directly activate non-cell cycle genes that inhibit cell proliferation.  
The glucocorticoid induced leucine zipper (GILZ) is a GR target gene with anti-proliferative 
effects. GILZ is a 137 amino acid leucine zipper (LZ) protein that is induced by GCs and has 
been most extensively studied in the context of GC effects on immune cells such as T-
lymphocytes (Ayroldi and Riccardi 2009).  GILZ does not contain a canonical DNA binding 
domain and has been shown to have cellular effects through interactions with other proteins via 
its LZ motif (Ayroldi and Riccardi 2009).  The GC-induced anti-proliferative effects of GILZ are 
mediated by binding of GILZ with activated Ras through the Ras tuberous sclerosis complex 
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(TSC).  The Ras-GILZ complex then forms a ternary complex with Raf leading to inhibition of 
both ERK-1/2 and AKT activity thereby causing a subsequent reduction in cell proliferation 
(Ayroldi et al. 2007).  Silencing of the GILZ gene inhibited the anti-proliferative effect of DEX 
on T cells.  Moreover, GILZ expression inhibited Ras/Raf dependent proliferation and Ras 
dependent transformation of NIH-3T3 cells (Ayroldi et al. 2007).  Interestingly, we observed a 
rapid increase in ERK-1/2 activity following GC exposure, but this increase is superimposed on 
a relatively high baseline level.  It is possible that while rapid non-classical GR activation 
decreases S-phase entry via ERK-1/2 mediated effects on GJIC, in the longer term, a GC-GILZ 
mediated reduction in ERK-1/2 activity may further decrease proliferation through genomic 
effects.  In addition, GILZ inhibition on AKT may further reduce proliferation.  This signaling 
pathway, which we did not analyze in detail in our studies, warrants further attention in future 
experiments. 
4.5 GC EFFECTS ON BIOLOGICAL RHYTMS 
A number of recent findings suggest that GC exposure can affect the periodic (circadian and/or 
ultradian) expression of certain GR target genes (Segall et al. 2009; So et al. 2009).  These 
studies add to a growing body of literature suggesting that biological rhythms are an important 
aspect of cell physiology, and that disruption of these rhythms can have effects on cell function.  
Interestingly, a select subset of these circadian genes (e.g. per1, Npas2, and per2) is also 
implicated in cell proliferation in various cell types including NPCs (Borgs et al. 2009; Lee et al. 
2010).   
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4.5.1 Per2 and Proliferation 
Per2, which is a transcription factor itself, is a particularly interesting example.  Per2 protein has 
been shown to modulate cell proliferation by directly up-regulating expression of the clock gene 
Bmal1 which is also a transcription factor that acts as a negative regulator of the cell cycle 
related gene c-myc.  C-myc protein up-regulates cyclin D1; therefore, per2 expression indirectly 
decreases cyclin D expression and inhibits proliferation by interrupting the G1 to S transition 
(Borgs et al. 2009).   In addition, the per2 promoter was shown to have a GRE.  Chromatin 
immunoprecipitation (ChIP) experiments revealed direct binding of DEX activated GR to the 
per2 promoter (So et al. 2009).  Intriguingly, while DEX exposure caused cycling of per2 
mRNA, time course ChIP experiments revealed that GR remained bound to the per2 promoter 
throughout the period of cycling (So et al. 2009).  This suggests that the cycling of per2 results 
from an event downstream of GR occupancy of the per2 promoter.  As a final twist linking per2 
with GC-induced rhythms, per2 gene expression is up-regulated by increases in IP3 mediated 
spikes in intracellular Ca2+ concentration, suggesting that per2 expression also may be 
influenced by alterations in GJIC (Takashima et al. 2006).  
Thus, GC exposure may be modulating circadian or rhythmic activity at multiple levels.  
On the one hand, GC exposure may be influencing the cycling of per2 through genomic 
mechanisms.  On the other hand, GC-mediated inhibition of GJIC may be disrupting Ca2+waves. 
This may have its own effects on proliferation including the potential modulation of per2 
expression.   
Interestingly, this kind of multi-level regulation (or dysregulation) of biological rhythms 
by GCs may partly explain some of the seemingly contradictory results that have been observed 
when examining the effects of hormone on the periodic cycling of a single factor.  In the case of 
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per2, DEX treatment leads to cycling of mRNA levels over 48hrs; yet examination of GR 
occupancy of the per2 promoter over the identical time course reveals no significant differences 
(So et al. 2009).  Perhaps this seemingly incongruous result can be explained by GC effects on 
the cycling of another factor that acts downstream of GR binding to the per2 promoter.  In this 
example, GC-induced changes in Ca2+ spikes may interact with per2 at the level of transcription 
to alter total per2 mRNA levels.  In theory, this may result from a Ca2+ regulated co-activator or 
co-repressor of per2 transcription.  Work by Takashima and colleagues that identified Ca2+ 
dependent transcription of per2 did not identify the specific transcriptional elements linking Ca2+ 
spikes with per2 transcription.  However, their work demonstrated that Ca2+ spikes up-regulated 
per2 expression, suggesting that a Ca2+ regulated co-activator or perhaps some transcriptional 
elements that release repression would underlie this process (Takashima et al. 2006). 
4.6 CONNEXINS AND NEURODEVELOPMENT 
If the loss of Cx43 mediated GJIC is critical for NPC proliferation, as our studies suggest, then a 
complete loss of Cx43, such as in a Cx43KO mouse, should have profound effects on the brains 
of these animals.  However, this is not the case.  Cx43KO is post-natal lethal due to defects in the 
ventricular outflow tract and stenosis of the pulmonary artery, but an examination of the post-
natal brain of Cx43KO mice reveals no gross abnormalities relative to their wildtype littermates 
(Dermietzel et al. 2000).  Cx43cKO mice that have cre driven by a GFAP promoter also display 
no evidence of neurodegeneration or astroglial abnormalities at birth.  However, mild 
impairments in motor abilities and an increased predilection for exploratory behavior were 
reported in adult mice (Frisch et al. 2003; Theis et al. 2003).  
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4.6.1 Connexins and Compensation 
The explanation for this seeming contradiction between our results and the observations noted 
above may lie primarily in the ability of other Cx isoforms to compensate for Cx43 deficits in the 
developing brain.  For example, Cx43 is the predominant (i.e. most abundant) Cx isoform in 
astrocytes, but an examination of astrocytes from Cx43KO animals revealed expression of Cx40 
and Cx45 by Northern blot, RT-PCR, and immunostaining, although these connexins were also 
detected in WT astrocytes (Dermietzel et al. 2000).  Perhaps more importantly, Cx30 protein 
expression by Western blot actually increased in Cx43KO astrocytes, indicating the activation of 
some sort of compensatory mechanism (Theis et al. 2003).  Up-regulation of the expression of 
select connexins, such as Cx30 in Cx43KO astrocytes, together with the sum of baseline function 
of other minor connexin isoforms may therefore compensate for the loss of a single connexin 
isoform, even if it is the predominant connexin in that particular cell type.  In fact, an 
examination of GJIC in cells with one of the Cx43 mutations that results in ODDD (discussed in 
Introduction), revealed that the mutant Cx43 isoform acts in a dominant negative fashion and 
actually inhibits GJIC from WT connexins (Flenniken et al. 2005).   This result indicates that the 
missense mutation in Cx43, if it compromised Cx43 function alone, may not be sufficient to 
cause the entire phenotype of ODDD.  Rather, the combination of non-functional Cx43 and the 
inhibitory effect of the mutated Cx43 on the function of other connexins conspires to lead to the 
complete phenotype of ODDD.   
Critically, in instances where compensation for Cx43 occurs, it likely does so over a 
relatively long time course; at least long enough for the translation of new connexin protein.  In 
contrast, the inhibition of Cx43 mediated GJIC by GC exposure occurs relatively rapidly, with 
activation of ERK-1/2 seen within two minutes of treatment, and decreased GJIC measured at 
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1hr.  Mechanisms necessary for the compensatory up-regulation of GJIC, such as translation of 
other connexin isoforms, probably cannot occur in this time window.  Moreover, it may be the 
case that the cellular signaling events that occur when Cx43 is knocked out or when it is mutated 
so it is non-functional, are distinct from those that occur when Cx43 GJIC is inhibited by 
phosphorylation.  Consequently, the signaling mechanisms that underlie compensation may not 
be activated during the GC induced reduction of GJIC.  In addition, compensatory mechanisms 
may only occur in certain cell types and in certain cellular contexts.  For example, Cx43KO leads 
to lethal cardiac defects indicating that compensation does not occur in these cells (Dermietzel et 
al. 2000).   In further support of this view, a reduction in Cx43 mediated GJIC in in-vitro NPCs 
resulting from a withdrawal of bFGF persisted even at 24hrs after bFGF withdrawal, the final 
time point tested (Cheng et al. 2004).  This suggests that perhaps neural progenitor cells are 
particularly susceptible to a reduction in Cx43 mediated GJIC. 
Importantly, our results and the findings of others cited above collectively suggest the 
importance of functional Cx43-mediated GJIC in neurodevelopment.  On the one hand, the 
instances where a loss of Cx43/GJIC leads to compensation by other connexins indicates that 
functional connexin-mediated GJIC is a biologically important phenomenon.  It is important 
enough from an evolutionary perspective that biologically expensive redundancies (i.e., 
expression of minor connexin isoforms and the ability to up-regulate other connexins) would be 
maintained in the event that the major connexin isoform becomes dysfunctional.  On the other 
hand, in instances where compensation for a reduction of GJIC does not occur, as we have 
observed, there is a pronounced physiological outcome.  In our model we observed an alteration 
in cell proliferation. 
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4.7 CLINICAL IMPLICATIONS 
GC hormones such as DEX are used clinically in a number of contexts. For example, 
GCs are used in both children and adults for the treatment of autoimmune and inflammatory 
disorders such as asthma, rheumatoid arthritis, and various allergies (Rhen and Cidlowski 2005).  
The impact of GCs on development is also exploited for the treatment of complications arising 
from premature birth and for the treatment of CAH (reviewed in Introduction) (Yeh et al. 2004; 
Vos and Bruinse 2010). However, the use of these hormones in neonates and antenatally is 
controversial because of increasing evidence of delayed effects on neurodevelopment (Yeh et al. 
2004).  For example, infants given DEX for 28 days for respiratory distress syndrome were 
found to have deficits in motor skills, motor coordination, and IQ at school age (Yeh et al. 2004).  
In many of these cases, classical GR transcriptional activity is cited as underlying 
neurodevelopmental effects of GCs.  However, our findings support the notion that GC 
hormones may alter NPC proliferation even following limited exposure to GC by activating a 
MAPK dependent non-classical signaling mechanism (Ross et al. 2002; Sabolek et al. 2006; 
Sundberg et al. 2006).   
Interestingly, our findings of rapid non-classical and non-genomic effects of GCs on NPC 
proliferation adheres to an important general principle that has been made in other contexts 
where rapid non-classical signaling by GR has been observed.  In particular, it appears that NPCs 
utilize non-classical signaling to rapidly initiate a program to reduce cell proliferation, which 
over a longer time course occurs by classical/genomic mechanisms.  This is akin to non-classical 
GC signaling events in the basolateral amygdala and hypothalamus (reviewed in Introduction-
“Non-Classical GR”) where rapid effects occurring in a non-classical and non-genomic manner 
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appear to be a precursor to similar effects over a longer time course that are mediated by 
classical GR signaling. 
The most straightforward clinical implication of these findings is that exposing the fetal 
brain to GC hormones even for a short period can activate signaling cascades that may be 
sufficient to have negative neurodevelopmental consequences.  According to this interpretation, 
the clinical use of GCs should be guided by the need to balance the potential benefits of hormone 
on lung and heart development versus the certain negative consequences on neurodevelopment.  
However, this data may also suggest an alternative clinical interpretation that is to some extent 
supported by the available clinical data.  Perhaps there is a time window during which the effects 
of GC exposure are largely or almost entirely beneficial, but that longer term or more prolonged 
exposure tips this balance in favor of negative effects of GC exposure.  In light of the data in our 
studies, this interpretation suggests that perhaps the rapid non-classical effects of GC exposure 
are reversible and temporary, and that the more deleterious consequences occur when 
classical/genomic programs are activated by more prolonged exposure to hormone.  The 
examination of proliferation from our own studies lends some credence to this idea since 
inhibition of GJIC alone reduced the number of NPCs actively in S-phase of the cell cycle but 
did not actually force NPCs to exit the cell cycle entirely.  Presumably, cell cycle exit is largely a 
classical GR effect, whereas decreased S-phase entry is a non-classical effect and may be 
reversible as long as classical GR signaling events are not activated.   
An examination of the clinical literature also suggests that long-term exposure to 
hormone may at least partly underlie some of the more serious negative consequences of pre and 
postnatal GC exposure.  For example, while DEX has historically been the major GC 
administered to preterm infants, a growing body of evidence suggests that hydrocortisone may be 
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a superior clinical alternative due to fewer side effects, including neurodevelopmental side 
effects (Lodygensky et al. 2005; Benders et al. 2009).  Although both DEX and hydrocortisone 
can cross the blood brain barrier, one of the critical differences between these two hormones is 
that hydrocortisone can be inactivated by 11β-HSD2, whereas DEX cannot.  This enzyme is 
highly expressed in the placenta as well as in the brain for the majority of gestation (Seckl 2004).   
Consequently, hydrocortisone administration may primarily activate non-classical signaling 
mechanisms in the brain before it is inactivated by 11β-HSD2.  In contrast, continuous DEX 
treatment will almost certainly activate classical GR signaling pathways since DEX cannot be 
inactivated by 11β-HSD2. 
The benefits of shorter hormone exposure have also been demonstrated by the treatment 
of premature infants with pulsatile DEX therapy, instead of continuous DEX.  This was shown to 
be clinically effective in decreasing chronic lung disease and the need for oxygen 
supplementation and was associated with a reduction in side effects.  In this study, infants were 
given two divided doses of DEX per day for three days, instead of a continuous treatment.   
While neurodevelopment was not monitored, other common side effects from continuous DEX, 
such as a significant decrease in weight gain and significant increases in mean arterial blood 
pressure were not observed (Brozanski et al. 1995).  While even a pulse of DEX may activate 
classical GR signaling mechanisms, pulse therapy presumably leads to a lower fetal DEX 
concentration between pulses than a continuous infusion, and may therefore primarily activate 
non-classical GR signaling pathways.  These findings are therefore important in two regards: 
First, they indicate that pulsed DEX dosing can be clinically effective.  Second, even though 
neurodevelopment was not assessed, they indicate that certain side effects are lower from a pulse 
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treatment.  These results warrant a more thorough examination of potential side effects, 
including on neurodevelopment, from pulse therapy.   
In summary, the clinical literature on prenatal and postnatal GC therapy suggests that 
while hormone treatment has an important, and in many contexts indispensable, therapeutic role, 
it is also associated with negative side effects.  Importantly, the negative effects vary depending 
on the particular GC used.  For example side effects from DEX tend to be more severe than with 
the use of the natural hormone, hydrocortisone.  Combining our results with other findings in the 
field, we can speculate that the negative outcome is partly a result of the activation of classical 
GR signaling which may irreversibly inhibit proliferation and/or alter the differentiation of 
developing NPCs.  Therefore, the selective activation of non-classical signaling pathways may 
preserve the clinical benefits of pre and postnatal GC therapy while avoiding some of the 
negative side effects.  This may be achieved by using natural GCs, pulse therapy of synthetic 
GCs, or membrane impermeable versions of synthetic or natural GCs that selectively activate 
non-classical signals. 
4.8 CONCLUSIONS AND FUTURE DIRECTIONS 
The work presented in this thesis identifies a rapid and non-classical GR-mediated inhibition of 
GJIC in neural progenitors that leads to subsequent alterations in cell proliferation.  Importantly, 
these studies have identified a novel target for membrane-initiated GR signaling in Cx43, and 
have demonstrated that even a short pulse of hormone can alter cell physiology in the form of 
proliferation via effects on Cx43-mediated GJIC.  Equally importantly, these studies build on 
and complement previous findings in the steroid hormone and connexin literature.  The rapid 
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signaling cascade appears to be initiated in a c-src dependent manner by a membrane GR that is 
associated with cav-1.  Hormone exposure led to downstream MAPK signaling and eventual 
ERK-1/2 phosphorylation of Cx43.  The signaling cascade that I identified is remarkably similar 
to non-classical ER signaling that utilizes some of the same protein co-factors (i.e., c-src and 
cav-1) and results in ERK-1/2 activation.  In addition, Cx43 phosphorylation by ERK-1/2 at the 
consensus ERK-1/2 target sites was known to lead to a loss of GJIC, in agreement with these 
findings.  In a broader sense, my finding also adds to the view that non-classical and classical 
steroid hormone signaling are intimately linked and lie on a continuum in which activation of 
one program complements the activation of the other (Haller et al. 2008).  In this particular case, 
rapid non-classical GR activation reduced S-phase progression of NPCs whereas slower acting 
classical GR activation was most likely responsible for forcing NPCs to exit the cell cycle 
entirely.   
There are also a number of avenues by which the work presented here can be expanded 
and built upon to further our understanding of GR signaling and its effects on cell physiology.  
We present evidence suggesting that GR is membrane localized and that it is associated with 
cav-1.  It would be interesting to see if the same mechanisms that underlie membrane 
localization of AR, PR, and ER also underlie GR membrane localization.  In order to address this 
possibility, the putative “membrane localization” sequence in the E-domain of GR could be 
mutated to prevent palmitoylation, as done previously by Pedram et al., (2007).  We could then 
assess palmitoylation in the native and mutated GR and also determine if membrane localization 
occurs in the mutant.  
Further use of cav-1 KO cells may definitively demonstrate the role of this protein in GR 
mediated modulation of NPC proliferation.  Studies of cav-1 KO animals have demonstrated an 
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increase in neural progenitor proliferation in adult mice (Jasmin et al. 2009).  Our studies suggest 
that cav-1 may have a similar anti-proliferative effect in NPCs.  It would therefore be 
informative to examine the rate of proliferation of cav-1 KO NPCs in the presence and absence 
of hormone.  If cav-1 is essential for GR non-classical signaling, we would expect that hormone 
treatment may not inhibit proliferation or at least S-phase entry following a transient exposure to 
GC.  It would be interesting to document if the level of proliferation in untreated cav-KO NPCs 
is also elevated compared to WT and to assess if longer (i.e. classical GR) hormone exposure has 
differential effects on cavKO NPC proliferation.  The latter may provide further insight into the 
role of cav-1 in mediating the divergence of non-classical and classical GR signaling.   
The precise structural make-up of the membrane GR signaling complex is not known, 
and gaining a more complete understanding of what this complex looks like would be very 
insightful.  In fact, even an examination of the ER literature does not clarify exactly how the 
hormone receptor and proteins such as cav-1 that it is purported to interact with associate within 
the physical space of the cell membrane.  In particular, is “membrane GR” located largely in the 
cytoplasm by the inner leaf of the cell membrane, within the cell membrane, outside the 
membrane facing the extracellular space, or some combination of the above?  Activation of GR 
by membrane-impermeable BSA conjugates has been used as evidence that some portion of the 
receptor faces the extracellular space, but BSA can be internalized within caveolae, thus 
discrediting this as definitive proof of GR localization outside the cell membrane (Levin 2005).   
Immunostaining of non-permeabilized cells has also been used as evidence that the 
hormone receptor is at least partly extracellular.  However, the limited resolution of standard 
light microscopy, as well the possibility of antibody penetration into caveolae make this a 
dubious assertion (Levin 2005).  More definitive evidence of GR localization at the membrane 
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may be gained by a combination of high-resolution EM studies as well as computational 
modeling of GR based on the list of known GR binding partners.  The latter technique could 
provide insight into potential conformational changes in GR within and around the membrane 
space.  Given the clear similarities between the superfamily of nuclear receptors, this sort of 
study will be particularly useful because of the potential generalizability of the findings. 
We also speculate that GR-induced reductions in GJIC contribute to alterations in NPC 
proliferation through a combination of Ca2+-dependent effects and Ca2+-independent effects 
mediated by classical GR signaling.  An important extension of this study would be to measure 
the effects of hormone treatment on intercellular Ca2+ levels using live cell imaging coupled with 
a Ca2+ sensitive ratiometric indicator like Fura-2.  The general methodology of hormone 
treatment and/or pharmacological inhibition of gap junctions followed by live cell imaging can 
be extended to examine the role of GJIC and the passage of any given cellular metabolite. For 
example, measuring ATP release by neurospheres using bioluminescent live cell imaging 
following blockade of gap junctions with cbx could reveal the importance of gap junction 
communication in the activity of this metabolite (Lin et al. 2007). 
Another important extension of our findings would be to identify gene targets of 1hr GC 
exposure that alter proliferation.  In the discussion section, a few potential candidates were 
identified based on the existing literature.  These targets can be broadly categorized into those 
proteins that could be altered by hormone effects on GJIC (i.e. Ca2+ target genes such as NFAT) 
and those proteins that potentiate cell cycle arrest by GR action that is independent of GR effects 
on GJIC.  While the approach of identifying a few select targets from the literature and 
measuring changes in their protein and/or mRNA expression may yield informative results, a less 
biased approach utilizing gene-chip technology may be especially useful in this setting.  For 
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example, a mini-array focused on cell cycle related and Ca2+ modified genes that utilizes cDNA 
from control, 1hr 1-heptanol, and 1hr DEX treated NPCs could be particularly insightful.  The 
more promising candidates from this type of broad search can then be validated and further 
probed using more traditional techniques.      
There are also a few very specific experiments that could reinforce the results that have 
been presented in this thesis.  Utilization of NPCs from GR knockout animals or knockdown of 
GR would allow confirmation of the role of GR in the non-classical signaling cascade that has 
been identified.  In addition, while we have shown that ERK-1/2 phosphorylates Cx43 at 
S279/S282, definitive proof of the role of this site in mediating GR induced reductions in GJIC 
would necessitate the use of a Cx43 phosphorylation mutant at these sites.  Activation of MAPK 
in cells transfected with this Cx43 mutant should not result in a reduction in GJIC.  Finally, 
while we have established a hormone-dependent reduction in GJIC in NPCs that is present at 
1hr, it would be useful to also know more about the dynamics of this process between the 
moments after hormone is first introduced up to 24hrs later.  In this regard, performing FRAP at 
time points prior to 1hr, such as at 30min, and between 1hr and 24hrs would be insightful.  The 
complementary experiment to this would be measuring Cx43 phosphorylation at s279/s282 at 
these time points as well.   
In a broader sense the objective of these studies was not only to understand the molecular 
mechanism whereby GCs alter GJIC in NPCs, but to also expand on our understanding of how 
GCs impact on human health and disease.  To this end, these studies have demonstrated that even 
a transient exposure to DEX leads to a loss in cell proliferation, and that a reduction in GJIC 
alone, one aspect of hormone exposure, reduces S-phase entry of NPCs.  These in-vitro results 
are admittedly far-removed from human clinical practice, but they can inform a program of 
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experiments that can be clinically useful.  An important next step would be to determine the 
impact of non-classical GR activity in-vivo on proliferation in the embryonic murine brain.  For 
example, it would be interesting to administer DEX-BSA to pregnant mice and then determine 
cell proliferation in the embryonic brain 24hrs later.  (Unfortunately, RU-486 cannot be used to 
limit hormone exposure after 1hr in-vivo, as was the case with our in-vitro experiments, because 
it will cause spontaneous abortions.)   
While we limited our studies to the use of DEX, the commonly clinically used synthetic 
GC betamethasone as well as the natural GC, corticosterone, could also be used in both in-vitro 
and in-vivo studies.  This kind of research program will allow for a determination of differential 
effects of various GCs and may also show us if the effects we have observed in-vitro are 
reproducible in-vivo.   In addition, continued in-vitro studies as highlighted previously will aid in 
the dissection of the mechanisms operating in classical and non-classical actions of steroid 
receptors and complement in-vivo studies.  This could reinvigorate the search for novel ligands 
that preferentially activate one pathway, either classical or non-classical, and otherwise provide 
potential targets that allow for more selective actions of hormone exposure.  Given the important 
clinical role of hormone therapies and the many negative side effects associated with their use, 
this presents the possibility of selectively eliciting only the positive effects of GC (or other 
hormone) therapy- an outcome with great therapeutic promise. 
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